[{"text": "Chairman David Mott Bets $1M on Ardelyx--Is This Biotech Stock Set to Skyrocket? Khac Phu Nguyen Thu, Jan 23, 2025, 9:41 PM 1 min read In This Article: ARDX -1.31% Ardelyx ( NASDAQ:ARDX ) just got a confidence boost from insider buying. Chairman David Mott scooped up 199,000 shares at an average price of $4.99, putting nearly $1 million on the line. The stock is hovering slightly higher at $5.05, but analysts are eyeing much bigger gains, with targets stretching from $5.50 to as high as $15.00. On the business side, Q4 numbers came in strongU.S. sales of Ibsrela hit $54 million, topping expectations. And for 2025, Ardelyx is forecasting Ibsrela revenue between $240 million and $250 million, outpacing analyst projections of $229.6 million. Warning! GuruFocus has detected 3 Warning Signs with ARDX. Financially, the company is holding its ground. It wrapped up 2024 with $319 million in unaudited U.S. net product sales and a solid $250 million in cash and investments. But it's not all smooth sailingMedicare coverage issues for its kidney drug XPHOZAH triggered a downgrade from H.C. Wainwright, moving the stock from Buy to Neutral. In response, Ardelyx is staying aggressive, pushing legislative efforts with the Kidney Patient Act while ramping up its IBSRELA sales force to keep momentum alive. Despite the headwinds, some analysts aren't backing down. Jefferies is still bullish, pointing to Ardelyx's proactive management and strategic pivots as reasons for optimism. With multiple analysts revising earnings estimates upward and management sharpening its commercial playbook, investors are watching closely to see if this biotech name can push through the noise and unlock its full upside potential. This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2025-01-23T18:41:31+00:00", "sentiment": {"score": 0.9114279728382826, "confidence": 0.9332126975059509, "probabilities": {"positive": 0.9332126975059509, "negative": 0.021784724667668343, "neutral": 0.0450025275349617}}, "embedding": [-0.08967215567827225, -0.14588873088359833, -0.06554197520017624, -0.021258534863591194, -0.04740004986524582, -0.1428729146718979, 0.10574943572282791, 0.08707252144813538, 0.08733247965574265, 0.053388845175504684, -0.09641707688570023, 0.15042385458946228, 0.03601106256246567, 0.000811801990494132, -0.16429290175437927, 0.047020938247442245, 0.019298814237117767, -0.16536912322044373, -0.07430849969387054, 0.13187888264656067, -0.03006850741803646, -0.035190142691135406, -0.05348888039588928, -0.00932662095874548, 0.08260200917720795, 0.005498681217432022, -0.01010976079851389, -0.03172235190868378, -0.12477628886699677, -0.12864260375499725, 0.020730802789330482, 0.10946247726678848, 0.013694672845304012, -0.08540909737348557, -0.02776521071791649, 0.04403955116868019, -0.07948913425207138, 0.05217443034052849, -0.0034018652513623238, 0.01735992729663849, 0.02659366838634014, -0.027795111760497093, -0.20108839869499207, -0.013550994917750359, 0.01113517303019762, -0.08964304625988007, 0.01235221978276968, -0.010076014325022697, 0.013957904651761055, 0.05836767330765724, -0.19635242223739624, -0.13663147389888763, 0.11176316440105438, 0.013863864354789257, -0.019773583859205246, 0.05107389762997627, -0.10347846895456314, -0.06516111642122269, 0.049871496856212616, 0.01567266695201397, 0.07192898541688919, 0.023026907816529274, -0.03540201485157013, 0.04066409170627594, 0.04696904122829437, -0.009689902886748314, -0.02543642930686474, -0.002855168655514717, -0.045916564762592316, 0.05944979563355446, 0.17371056973934174, -0.04779120534658432, -0.05657757818698883, -0.05098920688033104, -0.03496618568897247, 0.10904352366924286, 0.1493789255619049, -0.10104186832904816, 0.13650043308734894, -0.039404649287462234, 0.08916734904050827, -0.006966513581573963, 0.08068962395191193, -0.06907599419355392, -0.011174928396940231, 0.05975493788719177, 0.08406389504671097, 0.06030016764998436, 0.07946998625993729, -0.04345083236694336, 0.1354004442691803, -0.07332572340965271, 0.049434881657361984, 0.02386908233165741, 0.03379398211836815, 0.05754340812563896, 0.00905973557382822, -0.04976429417729378, -0.0838344395160675, 0.05976877361536026, 0.04674050956964493, 0.06730684638023376, 0.02149166166782379, -0.10744303464889526, -0.05128476396203041, -0.1302688717842102, 0.18089313805103302, -0.018238110467791557, -0.009310722351074219, 0.026545189321041107, -0.10730798542499542, 0.03192707151174545, -0.06526834517717361, -0.02950400672852993, -0.09733142703771591, 0.1803525686264038, -0.07913289219141006, 0.029809430241584778, 0.003890003077685833, -0.04920439422130585, 0.02971501648426056, 0.10213392227888107, -0.016224805265665054, 0.03986175358295441, 0.07355129718780518, 0.1399369090795517, -0.1871800273656845, 1.4701759439572559e-32, 0.006009402219206095, 0.07570666074752808, -0.050141360610723495, -0.054266370832920074, -0.0377822108566761, 0.026728946715593338, 0.07190822064876556, -0.0679977685213089, -0.054718513041734695, -0.046488817781209946, -0.1584649384021759, 0.030134055763483047, -0.031094947829842567, -0.008011405356228352, -0.011808841489255428, -0.05424710363149643, -0.07723589241504669, 0.07223866879940033, -0.020580248907208443, 0.010645785368978977, 0.09528090804815292, 0.00010862133785849437, -0.14226529002189636, 0.006393053103238344, -0.05344497412443161, 0.027304623275995255, 0.008519557304680347, 0.026011310517787933, 0.00974882859736681, 0.09044688940048218, -0.05498458817601204, 0.09735102206468582, -0.036645110696554184, -0.055127937346696854, -0.08890169113874435, -0.038190435618162155, -0.09173709899187088, -0.07997564971446991, 0.04109833762049675, 0.018052656203508377, -0.1863698810338974, 0.13254782557487488, -0.11249904334545135, -0.12543541193008423, 0.013759643770754337, -0.02080238237977028, -0.09542550891637802, 0.02117994986474514, -0.03396184742450714, -0.0380256287753582, -0.07488132268190384, 0.03326038643717766, 0.08823687583208084, -0.02496900036931038, -0.07102718204259872, -0.019382299855351448, -0.03272129222750664, -0.10689158737659454, 0.13398106396198273, 0.11165428161621094, 0.07465378195047379, 0.04442480579018593, 0.026319412514567375, 0.05376362428069115, -0.16298578679561615, 0.159645214676857, 0.04114526882767677, 0.006941435392946005, -0.11807740479707718, 0.17564362287521362, -0.013273518532514572, -0.05983543023467064, 0.1340731680393219, -0.10803305357694626, 0.09573528170585632, -0.132963627576828, -0.03795049712061882, -0.05224777013063431, 0.029485691338777542, 0.03918900340795517, -0.011524617671966553, -0.06213770806789398, 0.08934417366981506, 0.041075609624385834, 0.08535605669021606, -0.09719430655241013, -0.023809591308236122, 0.08768890798091888, -0.045515190809965134, 0.09984836727380753, 0.027873532846570015, -0.048997048288583755, -0.07899849861860275, 0.13096123933792114, -0.00991555955260992, -1.2343065372458343e-32, -0.02616128884255886, 0.0025358698330819607, -0.011907198466360569, -0.033356472849845886, -0.06794775277376175, 0.07610573619604111, 0.0983259528875351, 0.0468301847577095, 0.010698224417865276, -0.07429526001214981, 0.027267172932624817, 0.09081005305051804, -0.09654541313648224, 0.04670039936900139, -0.05399239808320999, -0.049963656812906265, 0.07491366565227509, -0.1266993284225464, 0.027250103652477264, -0.06529396772384644, 0.0046855853870511055, 0.05265495553612709, -0.20211531221866608, 0.11014648526906967, -0.03988778218626976, 0.11625638604164124, 0.06254777312278748, 0.04476640373468399, -0.025234099477529526, -0.021088458597660065, -0.129105344414711, -0.03172076493501663, -0.1710338294506073, 0.06694354116916656, -0.005828474182635546, 0.11514786630868912, 0.04708506911993027, -0.06915760785341263, -0.09159194678068161, -0.0621042363345623, 0.08258284628391266, 0.01675829477608204, 0.029797885566949844, 0.015138797461986542, 0.12928007543087006, -0.025478778406977654, 0.05002443864941597, -0.04543463885784149, 0.17844782769680023, -0.05373774841427803, 0.03552927449345589, 0.0024326774291694164, 0.13211247324943542, 0.12716050446033478, -0.0660456195473671, -0.019506283104419708, 0.015293356962502003, 0.021486962214112282, -0.03275818005204201, 0.006969858426600695, 0.005291292909532785, 0.113834448158741, 0.01816965639591217, -0.001478241290897131, -0.013348851352930069, 0.10025124251842499, 0.036022599786520004, -0.04331209510564804, 0.01272571925073862, -0.11081098020076752, -0.055747296661138535, -0.04374390468001366, -0.0023116893135011196, -0.034718386828899384, 0.062530018389225, 0.18573430180549622, -0.06911485642194748, -0.106843002140522, -0.027177494019269943, -0.02579825557768345, 0.10923071950674057, -0.006524090655148029, 0.03983977064490318, 0.03247147053480148, 0.006615255959331989, 0.04993776977062225, 0.039267100393772125, 0.025445247069001198, -0.024866463616490364, -0.007934101857244968, -0.09025668352842331, -0.029964910820126534, -0.06830096989870071, 0.032836075872182846, 0.08137063682079315, -1.0031448738345716e-07, -0.004746056627482176, -0.0450328029692173, 0.05248216167092323, -0.03407236188650131, 0.09253326058387756, -0.040934737771749496, 0.010320214554667473, 0.08024206757545471, 0.1384243667125702, 0.16880619525909424, 0.12542754411697388, 0.125122532248497, -0.09575224667787552, 0.025964079424738884, -0.006627339869737625, 0.028803352266550064, -0.13622020184993744, 0.00461634062230587, -0.026531243696808815, -0.05317244678735733, 0.00691483449190855, 0.06186839938163757, -0.0013173959450796247, -0.0503089539706707, 0.08366701006889343, -0.06821402162313461, -0.019808707758784294, 0.10196100920438766, -0.009047563187777996, 0.024087287485599518, -0.009230163879692554, 0.0025161418598145247, 0.010117007419466972, 0.05731355398893356, -0.06812078505754471, -0.03212043642997742, 0.06693808734416962, 0.08900800347328186, 0.09668886661529541, 0.0549226850271225, -0.08509497344493866, -0.046921998262405396, 0.0034166378900408745, -0.03989860787987709, -0.04765921086072922, -0.08380269259214401, -0.19188429415225983, -0.07757657021284103, 0.17216643691062927, -0.17387254536151886, 0.06885909289121628, -0.057509131729602814, 0.1266501098871231, 0.03464539349079132, 0.05238661170005798, -0.006278758868575096, -0.11662746965885162, -0.07605467736721039, -0.09941218048334122, 0.013990075327455997, 0.061019740998744965, -0.2742345929145813, -0.018373388797044754, 0.11643581092357635], "changes": {"1wk": -2.722324666724591}}, {"text": "Ardelyx (ARDX) Moves 16.0% Higher: Will This Strength Last? Zacks Equity Research Tue, Jan 14, 2025, 5:07 PM 2 min read In This Article: ARDX -1.31% ESPR +1.12% Ardelyx (ARDX) shares soared 16% in the last trading session to close at $5.88. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.9% loss over the past four weeks. The stock rallied after the company announced preliminary total U.S. net product sales of $319 million in 2024, backed by growing demand for its two drugs, Ibsrela and Xphozah. Ibsrela sales in the fourth quarter of 2024 are expected to be $54 million, bringing the full-year number to $158 million. Xphozah sales in the fourth quarter of 2024 are expected to be $57 million, adding up to approximately $161 million in 2024. In 2025, Ardelyx expects Ibsrela sales to be between $240 and $250 million. This biotechnology company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of +108.3%. Revenues are expected to be $108.51 million, up 215.8% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For Ardelyx, the consensus EPS estimate for the quarter has been revised 24.1% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ARDX going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Ardelyx is part of the Zacks Medical - Drugs industry. Esperion Therapeutics (ESPR), another stock in the same industry, closed the last trading session 2.6% lower at $2.28. ESPR has returned 4% in the past month. Esperion Therapeutics' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.12. Compared to the company's year-ago EPS, this represents a change of +76%. Esperion Therapeutics currently boasts a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ardelyx, Inc. (ARDX) : Free Stock Analysis Report Esperion Therapeutics, Inc. (ESPR) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2025-01-14T14:07:00+00:00", "sentiment": {"score": -0.5100757777690887, "confidence": 0.6987563967704773, "probabilities": {"positive": 0.18868061900138855, "negative": 0.6987563967704773, "neutral": 0.11256299167871475}}, "embedding": [-0.09493830800056458, -0.14726805686950684, -0.1108362227678299, 0.010538619942963123, -0.07933032512664795, -0.08290588855743408, 0.041624195873737335, 0.14181309938430786, 0.1152891218662262, 0.025060299783945084, -0.07436924427747726, 0.16797283291816711, -0.017244867980480194, -0.02006564289331436, -0.12434113025665283, 0.03725401684641838, 0.05014611780643463, -0.13852965831756592, -0.12196081131696701, 0.12673088908195496, -0.004669008310884237, -0.05074591934680939, -0.015541112050414085, -0.014099016785621643, 0.12614095211029053, 0.0031911637634038925, -0.013320088386535645, -0.04741941764950752, -0.15388703346252441, -0.1710415929555893, -0.057841233909130096, 0.06320705264806747, 0.10041046887636185, -0.049046073108911514, -0.025996260344982147, -0.0078071048483252525, -0.026999011635780334, 0.04153653234243393, 0.012978630140423775, -0.005211325362324715, -0.044014789164066315, -0.032453522086143494, -0.16432899236679077, -0.060424286872148514, -0.04215269535779953, -0.11976701766252518, 0.003625372424721718, 0.02428589016199112, 0.0411050021648407, 0.1372258961200714, -0.15539124608039856, -0.12309452891349792, 0.044245343655347824, 0.0952330231666565, -0.0814550444483757, 0.04858948662877083, -0.1301857829093933, -0.10846924781799316, 0.04107271879911423, 0.05732137709856033, 0.15562963485717773, 0.07981529086828232, -0.02902252972126007, 0.060140036046504974, 0.04796801134943962, -0.019271396100521088, 0.042462147772312164, -0.01880503073334694, -0.07167895138263702, 0.007361648604273796, 0.1550886034965515, -0.03754369542002678, -0.14229340851306915, -0.01924949511885643, -0.11445252597332001, 0.0797353982925415, 0.19486889243125916, -0.13134795427322388, 0.08049478381872177, -0.12503138184547424, 0.038643307983875275, 0.018032006919384003, 0.015082772821187973, -0.08307014405727386, 0.03934842720627785, 0.07357476651668549, 0.11655031889677048, 0.14952412247657776, 0.1023082584142685, 0.002561255358159542, 0.14633600413799286, -0.036752212792634964, -0.04201975092291832, 0.013582272455096245, 0.01739039644598961, 0.06934598088264465, -0.009891288354992867, -0.03632214665412903, -0.0023304116912186146, 0.06266061961650848, 0.09470245987176895, 0.13095834851264954, 0.013753917999565601, -0.09645288437604904, -0.0704273134469986, -0.16529230773448944, 0.20309902727603912, -0.02001877874135971, -0.03472442179918289, 0.09739165008068085, -0.11299300938844681, -0.004067314323037863, -0.10101448744535446, -0.011812775395810604, -0.10709550976753235, 0.1652088463306427, -0.03521685302257538, 0.023415740579366684, 0.058667365461587906, -0.008236025460064411, 0.05338069796562195, 0.15984846651554108, -0.00796122383326292, 0.05963104963302612, 0.046575214713811874, 0.09682725369930267, -0.178132101893425, 1.1919449534516639e-32, -0.053795237094163895, 0.058817338198423386, -0.09363887459039688, -0.025972062721848488, -0.03519166633486748, 0.08072607219219208, 0.0647590234875679, -0.04753083735704422, -0.10390765219926834, -0.043692171573638916, -0.25020623207092285, 0.08532894402742386, -0.007075927220284939, -0.050529010593891144, 0.06592965871095657, -0.04423996061086655, 0.007933239452540874, 0.07292886078357697, 0.07064502686262131, -0.0068232156336307526, 0.039222583174705505, -0.014701806008815765, -0.14968490600585938, 0.06409220397472382, -0.08454523980617523, 0.06995159387588501, -0.043915756046772, 0.06687548756599426, -0.07387958467006683, 0.06953975558280945, 0.017262011766433716, 0.05117994546890259, -0.026904068887233734, -0.06444816291332245, -0.08529438823461533, -0.04258398711681366, -0.029747188091278076, -0.020988566800951958, 0.14832067489624023, 0.004279194865375757, -0.10077756643295288, 0.1704380214214325, -0.18555986881256104, -0.15211011469364166, -0.008729931898415089, -0.03207945078611374, -0.07914787530899048, 0.038089871406555176, -0.004880489781498909, -0.06458959728479385, -0.07071174681186676, 0.04219745099544525, 0.03482691943645477, -0.04206268489360809, -0.08215005695819855, 0.04674271494150162, -0.11084526777267456, -0.09950525313615799, 0.11846956610679626, 0.12778885662555695, 0.0370018407702446, 0.23621606826782227, 0.10776488482952118, 0.013171197846531868, -0.16882342100143433, 0.16220366954803467, 0.03478328883647919, -0.00888568814843893, -0.14647144079208374, 0.18056374788284302, -0.0586545467376709, -0.0805249810218811, 0.1228065937757492, -0.13051235675811768, 0.16579042375087738, -0.12541800737380981, -0.025002965703606606, -0.024195706471800804, 0.1053474098443985, 0.0779276192188263, -0.028966322541236877, -0.05096869170665741, 0.015986107289791107, 0.10356906056404114, 0.023467127233743668, -0.033337026834487915, -0.018681315705180168, 0.09745879471302032, 0.006918956059962511, 0.09775180369615555, 0.09286392480134964, -0.06853462755680084, -0.15198001265525818, 0.08512668311595917, 0.023959005251526833, -1.0222564664387126e-32, -0.024793297052383423, 0.06667505949735641, -0.020477257668972015, -0.029030120000243187, -0.0652647316455841, 0.07409422844648361, 0.07362735271453857, 0.0830795094370842, -0.007018608972430229, -0.05662522092461586, 0.14439226686954498, 0.053580477833747864, -0.12057609856128693, 0.06397747993469238, -0.041422802954912186, -0.046020202338695526, 0.08228152990341187, -0.12126100063323975, 0.07611402869224548, -0.0950695127248764, -0.0514657199382782, 0.17187175154685974, -0.13894236087799072, 0.08880369365215302, 0.026532892137765884, 0.0885426253080368, 0.029100462794303894, 0.04517888277769089, -0.028929855674505234, -0.051345475018024445, -0.07021474093198776, -0.0336589515209198, -0.13995958864688873, 0.10534363985061646, -0.06679227948188782, 0.052100665867328644, 0.010689265094697475, -0.12890049815177917, -0.01350894570350647, -0.07738438993692398, 0.12530198693275452, 0.024597080424427986, 0.03926246985793114, 0.037930309772491455, 0.15305107831954956, 0.0015187319368124008, 0.08909878134727478, -0.040551744401454926, 0.25723952054977417, -0.053020164370536804, 0.026006273925304413, -0.011125041171908379, 0.014369864016771317, 0.08321553468704224, -0.06352896243333817, -0.014397051185369492, -0.028579656034708023, -0.026587802916765213, -0.1133577972650528, -0.04653436690568924, 0.005965431686490774, 0.15242524445056915, 0.026479672640562057, -0.00578130129724741, -0.006920307874679565, 0.036746662110090256, 0.020230017602443695, -0.03463238850235939, -0.00252482108771801, -0.14226287603378296, 0.06560343503952026, -0.02583359181880951, 0.09621763229370117, -0.036940060555934906, -0.031292349100112915, 0.1126701831817627, 0.03408677130937576, -0.18655046820640564, -0.02480473928153515, -0.08238345384597778, 0.04517154395580292, 0.10671040415763855, 0.03656475991010666, 0.06770803779363632, -0.11761012673377991, 0.10783454030752182, -0.02843221090734005, 0.05125174671411514, -0.041111309081315994, -0.022296341136097908, -0.07917997986078262, -0.051903948187828064, -0.0777965560555458, -0.038199953734874725, 0.09529087692499161, -1.001603209260793e-07, 0.027747342362999916, -0.036438655108213425, 0.07875805348157883, -0.04057912901043892, 0.10439829528331757, -0.0013484098017215729, 0.02892759069800377, 0.04778355360031128, 0.17278647422790527, 0.16068506240844727, 0.0824323520064354, 0.12649767100811005, -0.1395447999238968, 0.01686093769967556, -0.12590481340885162, 0.025116806849837303, -0.03451453521847725, 0.012298678047955036, 0.006983193568885326, -0.14739330112934113, -0.031858012080192566, 0.09401926398277283, 0.1397358477115631, -0.12477901577949524, 0.059304505586624146, -0.0888366773724556, -0.06970323622226715, -0.034079454839229584, -0.0483645498752594, -0.038843028247356415, 0.059371545910835266, -0.0008004298433661461, 0.08157245814800262, 0.08236253261566162, 0.017392270267009735, -0.11133421212434769, 0.016260361298918724, 0.08866605907678604, 0.02512163296341896, 0.04134664684534073, -0.07224401086568832, -0.07652214169502258, -0.03661396726965904, -0.009804248809814453, -0.03044334053993225, -0.0683460608124733, -0.13756705820560455, -0.13643932342529297, 0.09749104082584381, -0.22901251912117004, 0.09858912229537964, -0.10103334486484528, 0.1620430052280426, -0.0412597730755806, 0.009542418643832207, 0.06307735294103622, -0.16693249344825745, -0.07621070742607117, -0.08778964728116989, -0.022973883897066116, 0.11147396266460419, -0.2574395537376404, -0.017524363473057747, 0.14232906699180603], "changes": {"1wk": -10.854086638768015}}, {"text": "Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities Ardelyx, Inc. Mon, Jan 13, 2025, 4:03 PM 8 min read In This Article: ARDX -1.31% Ardelyx, Inc. Company achieved significant commercial progress in 2024, finishing with total U.S. net product sales revenue of approximately $319 million\u00a0(unaudited) Company reaffirms peak U.S. net IBSRELA sales revenue of greater than $1 Billion Company announces peak U.S. net XPHOZAH sales revenue of $750 million Company finishes 2024 with approximately $250 million in cash, cash equivalents and investments\u00a0(unaudited) WALTHAM, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today provided an update on the company\u2019s progress in 2024 and initial expectations for 2025. \u201cIn 2024, Ardelyx delivered another year of sustained growth and exceptional performance. The growing demand for IBSRELA and XPHOZAH, both important, first-in-class medicines, has demonstrated that there is a clear unmet need among patients for differentiated therapeutic options,\u201d said Mike Raab, president and chief executive officer. \u201cIt is an incredibly exciting time for our company with tremendous opportunities in front of us. As you saw in the performance during the fourth quarter, the team is delivering on the promise of IBSRELA. This performance reaffirms our expectation that IBSRELA can achieve greater than $1 billion in annual sales at peak. In 2024, XPHOZAH\u2019s performance demonstrated its critical role in the treatment of hyperphosphatemia where there continues to be a high unmet need among patients. It is evident that there is a significant opportunity for XPHOZAH and we expect this product will achieve $750 million in annual sales at peak.\u201d Raab continued, \u201cIn 2025, we will be focused on our strategic priorities: Maintaining our growth momentum, building a pipeline and delivering a strong financial performance. We remain steadfast in our commitment to operational excellence and to making decisions in the best interest of patients and our shareholders.\u201d IBSRELA \u00ae (tenapanor) records approximately $158 million in net product sales revenue in 2024 U.S. net product sales revenue for IBSRELA during the fourth quarter is expected to be approximately $54 million, with full year net product sales revenue totaling approximately $158 million, subject to adjustment in connection with preparation of audited financial statements. IBSRELA performance demonstrated consistent quarter-over-quarter growth throughout the year, accelerating in the fourth quarter following the completion of the company\u2019s field-based sales team expansion. In 2025, the company will focus on continued commercial execution to maintain the strong momentum for IBSRELA. Story Continues Ardelyx currently expects full-year 2025 U.S. net product sales revenue for IBSRELA to be between $240.0 and $250.0 million. Ardelyx continues to expect IBSRELA to achieve greater than ten percent market share at peak and generate more than $1.0 billion in annual U.S. net product sales revenue before patent term expiration. Strong XPHOZAH \u00ae (tenapanor) performance continues, recording approximately $161 million net product sales revenue during 2024 XPHOZAH demonstrated an exceptional launch and finished its first full year of commercialization with 2024 U.S. net product sales revenue of approximately $161 million, including approximately $57 million in net product sales during the fourth quarter, subject to adjustment in connection with preparation of audited financial statements. The strong response from the prescribing community to XPHOZAH continued throughout the year, with feedback reflecting positive patient experiences and outcomes. XPHOZAH saw continued, quarter-over-quarter growth across all key indicators. At peak, Ardelyx currently expects XPHOZAH to achieve $750 million in annual U.S. net product sales revenue before patent term expiration. Coverage for oral only therapies, including XPHOZAH, is no longer available under Medicare Part D as of January 1, 2025. Access to XPHOZAH remains through a prescription written by a qualifying healthcare provider sent to Transition Pharmacy, the ArdelyxAssist specialty pharmacy partner. Patients who do not have affordable access will be evaluated for eligibility to receive XPHOZAH through the Ardelyx patient assistance program. Strong Cash Position As of December 31, 2024, the company had total cash, cash equivalents and short-term investments of approximately $250 million (unaudited). Ardelyx had approximately 238 million shares outstanding as of December 31, 2024. Company Presentation at 42 nd Annual J.P. Morgan Healthcare Conference The company will present and provide a business update at the 42 nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 7:30pm ET / 4:30pm PT. A webcast of the presentation can be accessed by visiting the Investor page of the company's website, www.ardelyx.com , and will be available on the website for at least 30 days following the call. IMPORTANT SAFETY INFORMATION (IBSRELA) WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS IBSRELA is contraindicated in patients less than 6 years of age; in nonclinical studies in young juvenile rats administration of tenapanor caused deaths presumed to be due to dehydration. Avoid use of IBSRELA in patients 6 years to less than 12 years of age. The safety and effectiveness of IBSRELA have not been established in patients less than 18 years of age. CONTRAINDICATIONS IBSRELA is contraindicated in patients less than 6 years of age due to the risk of serious dehydration. IBSRELA is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction. WARNINGS AND PRECAUTIONS Risk of Serious Dehydration in Pediatric Patients IBSRELA is contraindicated in patients below 6 years of age. The safety and effectiveness of IBSRELA in patients less than 18 years of age have not been established. In young juvenile rats (less than 1 week old; approximate human age equivalent of less than 2 years of age), decreased body weight and deaths occurred, presumed to be due to dehydration, following oral administration of tenapanor. There are no data available in older juvenile rats (human age equivalent 2 years to less than 12 years). Avoid the use of IBSRELA in patients 6 years to less than 12 years of age. Although there are no data in older juvenile rats, given the deaths in younger rats and the lack of clinical safety and efficacy data in pediatric patients, avoid the use of IBSRELA in patients 6 years to less than 12 years of age. Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe diarrhea occurs, suspend dosing and rehydrate patient. MOST COMMON ADVERSE REACTIONS The most common adverse reactions in IBSRELA-treated patients (incidence \u22652% and greater than placebo) were: diarrhea (16% vs 4% placebo), abdominal distension (3% vs <1%), flatulence (3% vs 1%) and dizziness (2% vs <1%). INDICATION IBSRELA (tenapanor) is indicated for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adults. Please see full Prescribing Information , including Boxed Warning, for additional risk information. IMPORTANT SAFETY INFORMATION (XPHOZAH) CONTRAINDICATIONS XPHOZAH is contraindicated in: Pediatric patients under 6 years of age Patients with known or suspected mechanical gastrointestinal obstruction WARNINGS AND PRECAUTIONS Diarrhea Patients may experience severe diarrhea. Treatment with XPHOZAH should be discontinued in patients who develop severe diarrhea. MOST COMMON ADVERSE REACTIONS Diarrhea, which occurred in 43-53% of patients, was the only adverse reaction reported in at least 5% of XPHOZAH-treated patients with CKD on dialysis across trials. The majority of diarrhea events in the XPHOZAH-treated patients were reported to be mild-to-moderate in severity and resolved over time, or with dose reduction. Diarrhea was typically reported soon after initiation but could occur at any time during treatment with XPHOZAH. Severe diarrhea was reported in 5% of XPHOZAH-treated patients in these trials. INDICATION XPHOZAH (tenapanor), 30 mg BID, is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. For additional safety information, please see full Prescribing Information . About Ardelyx, Inc. Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA \u00ae (tenapanor) and XPHOZAH \u00ae (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL \u00ae (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter) , LinkedIn and Facebook . Forward Looking Statements To the extent that statements contained in this press release are not descriptions of historical facts regarding Ardelyx, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Reform Act of 1995, including Ardelyx\u2019s currents expectations regarding: opportunities for continued adoption of IBSRELA and XPHOZAH, the annual U.S. net product sales revenue for IBSRELA at peak; the annual U.S. net product sales revenue for XPHOZAH at peak; net product sales revenue for IBSRELA for full year 2024 and the fourth quarter ended December 31, 2024; net product sales revenue for IBSRELA for full year 2025; the potential market share for IBSRELA at peak; net product sales revenue for XPHOZAH for the full year 2024 and the fourth quarter ended December 31, 2024; and its cash position at December 31, 2024. Such forward-looking statements involve substantial risks and uncertainties that could cause Ardelyx's future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, uncertainties associated with the development of, regulatory process for, and commercialization of drugs in the U.S. and internationally. Ardelyx undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ardelyx's business in general, please refer to Ardelyx's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on October 31, 2024, and its future current and periodic reports to be filed with the Securities and Exchange Commission. Investor and Media Contacts: Caitlin Lowie clowie@ardelyx.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2025-01-13T13:03:00+00:00", "sentiment": {"score": 0.9113029865548015, "confidence": 0.9209596514701843, "probabilities": {"positive": 0.9209596514701843, "negative": 0.009656664915382862, "neutral": 0.0693836584687233}}, "embedding": [-0.12341013550758362, -0.11143463850021362, -0.06859858334064484, -0.07187768816947937, -0.11247298121452332, -0.1006675511598587, 0.047633152455091476, 0.16590818762779236, 0.08166010677814484, 0.010023371316492558, -0.1000172346830368, 0.08168685436248779, 0.0054551661014556885, 0.07128337770700455, -0.06292852759361267, 0.0020243332255631685, 0.008596603758633137, -0.09481507539749146, -0.12843561172485352, 0.08052398264408112, 0.08773890137672424, -0.04850379750132561, -0.029916681349277496, 0.032688602805137634, -0.017805583775043488, 0.03312195464968681, -0.038833796977996826, -0.08538423478603363, -0.13185234367847443, -0.11045344173908234, 0.016200238838791847, 0.0777546837925911, 0.11273521184921265, -0.13351815938949585, -0.008240338414907455, 0.10462938249111176, -0.08586977422237396, 0.062195464968681335, -0.08963801711797714, -0.05736159533262253, -0.03847190737724304, -0.09666020423173904, -0.14067518711090088, 0.007426119409501553, 0.060178086161613464, -0.188228577375412, 0.02638651430606842, -0.0053788102231919765, -0.010113288648426533, 0.18792057037353516, -0.18267527222633362, -0.11743991822004318, 0.02847444824874401, 0.07447086274623871, 0.016537971794605255, 0.035268474370241165, -0.11253499984741211, -0.059947170317173004, -0.07696664333343506, -0.024072546511888504, 0.012571902945637703, -0.05914570018649101, -0.03677964210510254, -0.001349711325019598, 0.007916538044810295, 0.025585968047380447, 0.027382247149944305, -0.028426336124539375, -0.07519938051700592, 0.04230502247810364, 0.14409387111663818, -0.0957949310541153, -0.02188609354197979, 0.05020079389214516, -0.02223759889602661, 0.13817322254180908, 0.17415335774421692, -0.04710401967167854, 0.1084732711315155, -0.04096563905477524, 0.14130838215351105, 0.03637982904911041, 0.050144731998443604, -0.03364989906549454, -0.0024449429474771023, 0.07441776990890503, 0.025094609707593918, 0.08829890191555023, 0.03194427490234375, -0.0032397774048149586, 0.11623430252075195, 0.019658908247947693, 0.017201188951730728, 0.017184611409902573, -0.028398171067237854, 0.03679497167468071, -0.0019804793410003185, -0.016953926533460617, 0.017467789351940155, 0.017411842942237854, 0.02866426855325699, 0.04771754890680313, -0.02049248106777668, -0.12205573916435242, -0.06136157363653183, -0.149341881275177, 0.11666539311408997, -0.02763231098651886, 0.003981372341513634, 0.08938641846179962, -0.11721935868263245, -0.03457792103290558, -0.04459627345204353, 0.02228877879679203, -0.06905026733875275, 0.17733559012413025, -0.0508030503988266, 0.03507294878363609, 0.09828852117061615, -0.043297674506902695, -0.02440725639462471, 0.11279527842998505, -0.007799459155648947, -0.017540931701660156, 0.03106163628399372, 0.08057277649641037, -0.08327323943376541, 1.1091133032105898e-32, -0.08901052176952362, 0.040543705224990845, -0.03976893424987793, 0.031546011567115784, -0.05074046179652214, 0.04015399515628815, 0.05618448555469513, -0.01619173213839531, -0.1001279354095459, -0.09002642333507538, -0.16938605904579163, 0.06220584362745285, 0.01638851687312126, 0.05914895609021187, 0.06991640478372574, -0.05104851722717285, -0.04234524071216583, 0.0994492769241333, 0.04086762294173241, 0.016294652596116066, 0.04984229803085327, -0.01955891028046608, -0.09921853244304657, 0.07076989859342575, -0.12455667555332184, 0.10221707820892334, -0.007850486785173416, 0.05764476954936981, 0.016736885532736778, 0.06478673219680786, -0.01846507005393505, 0.05415099859237671, 0.0006439285352826118, -0.14973604679107666, -0.12061633169651031, -0.03788670897483826, -0.058809250593185425, -0.09760220348834991, 0.054450005292892456, 0.018471119925379753, -0.12433479726314545, 0.10945965349674225, -0.14025408029556274, -0.06668312102556229, 0.05963064730167389, -0.037625640630722046, -0.09073331207036972, 0.05617767572402954, -0.04106559604406357, -0.06476536393165588, -0.07877813279628754, 0.06520168483257294, 0.052118971943855286, -0.044258665293455124, -0.055550217628479004, 0.0053044394589960575, -0.09359145909547806, -0.057919278740882874, 0.11413167417049408, 0.12166959047317505, 0.012084663845598698, 0.05592917278409004, 0.018660474568605423, 0.062338508665561676, -0.07076304405927658, 0.1052527129650116, 0.07142352312803268, -0.07057243585586548, -0.08380661904811859, 0.09095942974090576, -0.017625167965888977, -0.11705903708934784, 0.08068321645259857, -0.047954101115465164, 0.13440124690532684, -0.095298171043396, 0.05347706377506256, 0.05523653328418732, 0.07023763656616211, 0.07803444564342499, -0.06411344558000565, 0.029406525194644928, -0.04480478912591934, 0.118836410343647, 0.11846670508384705, -0.03960128128528595, 0.043737880885601044, 0.04318343102931976, -0.07783309370279312, 0.033662836998701096, 0.06721088290214539, -0.007473617792129517, -0.11973389238119125, 0.1556362509727478, 0.017671052366495132, -1.0944944146533823e-32, 0.06869036704301834, 0.019035927951335907, -0.012386348098516464, -0.029513061046600342, 0.036325208842754364, 0.11663477122783661, 0.045819975435733795, -0.08141273260116577, 0.06526961177587509, -0.03715109825134277, 0.11023715138435364, 0.05858248472213745, -0.0477762371301651, 0.02881508134305477, -0.11114217340946198, -0.04195867106318474, 0.06605452299118042, -0.14412043988704681, 0.007642485201358795, -0.017377540469169617, 0.04879315197467804, 0.15267038345336914, -0.1434539556503296, 0.05036745220422745, -0.02862544357776642, 0.09223680198192596, 0.04594399034976959, 0.018786348402500153, 0.01856015808880329, -0.0601378008723259, -0.10256621241569519, -0.02413741685450077, -0.27842897176742554, -0.02389376610517502, -0.028152553364634514, 0.029613979160785675, 0.03884900361299515, -0.13876453042030334, -0.03154977783560753, -0.018465222790837288, 0.06503475457429886, -0.011142528615891933, -0.06500037014484406, 0.043048955500125885, 0.12262485921382904, -0.05342370271682739, 0.055978886783123016, -0.05736907571554184, 0.14959603548049927, -0.06689570099115372, 0.03782754763960838, -0.02454230934381485, -3.012828528881073e-05, -0.0012043104507029057, -0.048198726028203964, -0.0437980517745018, -0.007268248125910759, -0.0847012847661972, -0.01074889861047268, -0.03358864784240723, 0.01259048655629158, 0.10212354362010956, 0.05268441140651703, 0.03353581577539444, -0.009738396853208542, 0.14773046970367432, 0.11316731572151184, -0.058051757514476776, -0.014502218924462795, -0.13182707130908966, 0.0014866340206936002, -0.004526190459728241, -0.013681845739483833, -0.039083752781152725, -0.02650502510368824, 0.08790843933820724, -0.017274465411901474, -0.13773196935653687, -0.04836995527148247, -0.14034536480903625, 0.029868585988879204, 0.012808241881430149, -0.013763820752501488, 0.041377417743206024, -0.04200286045670509, 0.006553934421390295, 0.03279747813940048, -0.025519339367747307, -0.022208746522665024, 0.0643615573644638, -0.09010861814022064, -0.0002270713448524475, -0.10522053390741348, 0.05719565227627754, 0.11291693896055222, -1.0143872941625887e-07, 0.058534108102321625, 0.010085104033350945, 0.054439477622509, -0.03366084024310112, 0.04885996878147125, -0.08467262983322144, -0.0794050395488739, 0.10915093123912811, 0.1379678100347519, 0.18806996941566467, 0.08450168371200562, 0.14574486017227173, -0.046804919838905334, 0.06486745923757553, -0.025756830349564552, 0.0929596945643425, -0.023225856944918633, 0.06643456220626831, -0.03252006694674492, -0.07882517576217651, -0.06923533231019974, 0.0707264170050621, 0.047077324241399765, -0.12971755862236023, 0.04734266176819801, -0.09637924283742905, 0.025207342579960823, 0.008253749459981918, -0.028694242238998413, -0.057924535125494, 0.06912293285131454, -0.043122559785842896, 0.06628111004829407, 0.04245948791503906, -0.007443449459969997, -0.1456008106470108, 0.0008827727288007736, 0.08553703129291534, 0.013956688344478607, -0.0031491052359342575, -0.0859624594449997, -0.04471400007605553, -0.004254089668393135, 0.047189630568027496, -0.05256813392043114, -0.12563757598400116, -0.1587235927581787, -0.035595886409282684, 0.041081055998802185, -0.11181191354990005, 0.022636650130152702, -0.05133455619215965, 0.09797336161136627, -0.11568945646286011, 0.005319067742675543, 0.1073981374502182, -0.04518694803118706, -0.11011148989200592, -0.03849309682846069, 0.01093273051083088, 0.14486250281333923, -0.19522088766098022, 0.028768494725227356, 0.03672896698117256], "changes": {"1wk": -14.795916133103738}}, {"text": "Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference Ardelyx, Inc. Mon, Jan 6, 2025, 4:00 PM 1 min read In This Article: ARDX -1.31% Ardelyx, Inc. WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, President and CEO, will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 4:30pm PT in San Francisco. To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations . A replay of the panel presentation will be available on the Ardelyx website for 30 days following the event. About Ardelyx, Inc. Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA \u00ae (tenapanor) and XPHOZAH \u00ae (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL \u00ae (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter) , LinkedIn and Facebook . Investor and Media Contacts: Caitlin Lowie clowie@ardelyx.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2025-01-06T13:00:00+00:00", "sentiment": {"score": 0.08799863141030073, "confidence": 0.09710332751274109, "probabilities": {"positive": 0.09710332751274109, "negative": 0.009104696102440357, "neutral": 0.8937920331954956}}, "embedding": [-0.10211652517318726, -0.13617612421512604, -0.05809371918439865, -0.044050369411706924, -0.011871165595948696, -0.0712965577840805, 0.047772880643606186, 0.13855719566345215, 0.04074261337518692, 0.05369361862540245, 0.009489634074270725, 0.11698702722787857, 0.0689610168337822, 0.16820381581783295, -0.060585662722587585, -0.04050811007618904, 0.05985866114497185, 0.014884788542985916, -0.10404786467552185, 0.12876245379447937, 0.15561622381210327, 0.028928276151418686, 0.02413766086101532, 0.0387064553797245, -0.006975439842790365, -0.014807929284870625, 0.025858355686068535, -0.02659536525607109, -0.16178256273269653, -0.052870944142341614, -0.051650270819664, 0.011562434025108814, 0.08105448633432388, -0.10961444675922394, 0.03349791467189789, 0.10079599916934967, -0.1889868825674057, 0.05185997486114502, -0.1789482980966568, -0.03197583928704262, -0.07972323149442673, -0.1141061931848526, -0.036835722625255585, -0.06899948418140411, 0.040287379175424576, -0.12753921747207642, -0.009299147874116898, 0.03230293095111847, -0.05821404233574867, 0.21142593026161194, -0.15257251262664795, -0.13554710149765015, 0.08385021239519119, 0.05557304620742798, 0.02260063774883747, -0.06069614365696907, -0.15895147621631622, -0.06901711225509644, -0.07092108577489853, -0.033342279493808746, -0.019268672913312912, 0.013844878412783146, -0.12486030906438828, 0.05421717092394829, -0.09169043600559235, 0.09735267609357834, 0.026592129841446877, -0.0012212852016091347, 0.06779828667640686, -0.006797068752348423, 0.119771808385849, -0.11108677089214325, 0.09435789287090302, 0.05293356254696846, -0.07620342820882797, 0.11998683214187622, 0.14882028102874756, -0.01985812373459339, 0.056178074330091476, -0.014321237802505493, 0.13681325316429138, 0.1601576805114746, 0.15165074169635773, -0.04938909411430359, 0.10535626858472824, 0.13777603209018707, -0.05635829642415047, 0.15047958493232727, 0.05572060868144035, -0.05167112872004509, 0.1585838794708252, 0.13199180364608765, -0.0022049942053854465, 0.01714446395635605, 0.02478991076350212, -0.05166009068489075, 0.0065691471099853516, 0.0653454139828682, -0.02685561031103134, -0.029349517077207565, 0.021925063803792, 0.05591209977865219, -0.015044357627630234, -0.09849271178245544, 0.015784163028001785, -0.09245575219392776, 0.07799451053142548, -0.04212208837270737, 0.03928075730800629, 0.08088050782680511, -0.09157754480838776, 0.014301813207566738, -0.0076154135167598724, -0.07471570372581482, -0.10384699702262878, 0.222575381398201, 0.03513725474476814, 0.04648997634649277, 0.13231401145458221, -0.01701584830880165, -0.06243124604225159, 0.01857815310359001, -0.00467725470662117, -0.09590987861156464, 0.16330330073833466, 0.18894708156585693, -0.12322317808866501, 8.930780126805928e-33, -0.11259178072214127, 0.09553733468055725, -0.029135914519429207, 0.049743592739105225, 0.03431909531354904, -0.009728518314659595, 0.012005683965981007, -0.06745592504739761, -0.07250706851482391, -0.10426082462072372, -0.061890773475170135, 0.06363679468631744, 0.017735324800014496, 0.0171787291765213, -0.047633975744247437, -0.03960730507969856, -0.037647828459739685, 0.10420645773410797, 0.028515320271253586, 0.0673036277294159, 0.10219258815050125, 0.011072332970798016, -0.06089109927415848, 0.10519567877054214, -0.18510985374450684, 0.16519220173358917, 0.01730162464082241, 0.11220639944076538, 0.04651350528001785, 0.09485233575105667, 0.02045883797109127, 0.009144109673798084, -0.018125824630260468, -0.17219147086143494, -0.15111027657985687, -0.03390403464436531, -0.08366846293210983, -0.11154966801404953, 0.038455650210380554, -0.021306611597537994, -0.101288802921772, 0.018416035920381546, -0.1501571536064148, 0.007297610864043236, 0.16605441272258759, -0.12861604988574982, -0.09876633435487747, 0.12619109451770782, 0.06928998976945877, -0.064504474401474, -0.06351622194051743, -0.016860220581293106, 0.0526961088180542, -0.1035090908408165, -0.04100627452135086, 0.03658750653266907, -0.09395890682935715, -0.06888847798109055, 0.11928043514490128, 0.08802231401205063, 0.01906519941985607, 0.08689840137958527, 0.02721332386136055, 0.04257597029209137, -0.0806361734867096, 0.007006068713963032, 0.0035499469377100468, -0.1489403247833252, -0.09185447543859482, 0.04227888584136963, 0.09590232372283936, -0.02846357971429825, 0.05665676295757294, 0.014621582813560963, 0.15814201533794403, -0.10294820368289948, 0.11284762620925903, 0.0537874661386013, 0.028158918023109436, -0.0087958462536335, -0.04720412567257881, -0.011081687174737453, -0.02517055533826351, 0.22946900129318237, 0.06638447195291519, -0.04567715898156166, 0.016680991277098656, 0.10793300718069077, -0.07243666052818298, 0.022248797118663788, 0.12666833400726318, -0.044399604201316833, -0.1428927332162857, 0.08834636211395264, -0.04967604577541351, -7.199183643180602e-33, 0.07482130080461502, -0.002491585910320282, 0.0029011822771281004, -0.004000022076070309, -0.030309416353702545, 0.12813343107700348, 0.08016166090965271, -0.07721708714962006, 0.12805268168449402, -0.17298288643360138, 0.12617672979831696, 0.05598624050617218, -0.111005999147892, 0.006481062155216932, -0.10598292201757431, 0.1161075010895729, 0.02202659659087658, -0.036872122436761856, -0.020527193322777748, 0.06220172345638275, 0.026185819879174232, 0.008918428793549538, -0.05723204091191292, 0.004533978644758463, 0.015585280954837799, 0.012753404676914215, 0.14013229310512543, 0.049352362751960754, 0.02918882481753826, 0.00436399457976222, -0.10956310480833054, 0.03173747658729553, -0.2986292243003845, -0.0034558014012873173, -0.10742533206939697, 0.05361106991767883, 0.02246510237455368, -0.1542232483625412, -0.048709992319345474, -0.09579029679298401, 0.044794827699661255, -0.025079254060983658, -0.03998563811182976, -1.7926755390362814e-05, 0.03633778169751167, 0.04401807114481926, 0.01720743253827095, -0.07531196624040604, 0.05105813592672348, -0.12282110750675201, -0.001674451632425189, -0.03373614698648453, 0.06151307001709938, 0.0031363859307020903, -0.06938701868057251, 0.028205951675772667, -0.03523315116763115, -0.01447504386305809, -0.027624931186437607, 0.020156431943178177, -0.023711470887064934, 0.08387868106365204, -0.0033720743376761675, -0.007517207879573107, 0.02604818344116211, 0.14363780617713928, 0.16130036115646362, 0.0520353838801384, -0.018999194726347923, -0.12304884940385818, -0.05140291154384613, 0.04271169379353523, -0.008541425690054893, -0.011394118890166283, 0.03615845367312431, 0.10119986534118652, 0.017163418233394623, -0.09407832473516464, -0.10702016949653625, -0.13554416596889496, 0.1404273808002472, -0.0069184028543531895, -0.1070975586771965, 0.029771581292152405, -0.013353601098060608, 0.03218403831124306, 0.03472382575273514, -0.007992476224899292, -0.006168104708194733, 0.09670472890138626, -0.11186561733484268, 0.0623214915394783, -0.13678191602230072, 0.07449819892644882, 0.15749409794807434, -1.0005135209212312e-07, 0.06859153509140015, -0.03488105535507202, 0.04171136021614075, -0.162959024310112, -0.026665370911359787, -0.04707992076873779, -0.042846500873565674, 0.029564056545495987, 0.03949473053216934, 0.08200649172067642, 0.05033719539642334, 0.20239080488681793, -0.04377082362771034, 0.0566435270011425, -0.08899104595184326, -0.010109439492225647, 0.0885792225599289, 0.10311253368854523, -0.049085583537817, -0.03559879586100578, -0.11344078928232193, 0.09188023954629898, 0.05496177077293396, -0.1444929838180542, 0.06471406668424606, -5.434901686385274e-05, 0.041829612106084824, -0.026500817388296127, -0.008895033970475197, -0.15598712861537933, 0.003593823639675975, 0.022217147052288055, 0.012163360603153706, 0.0519256517291069, -0.0841159000992775, -0.1264120638370514, -0.04135333374142647, 0.04144586995244026, 0.022160179913043976, -0.017957380041480064, -0.13363753259181976, -0.1273627132177353, -0.029846658930182457, 0.00611793901771307, -0.07943110913038254, -0.037573881447315216, -0.12940974533557892, -0.03275762498378754, 0.07386504858732224, -0.019661229103803635, -0.03008367493748665, -0.04286577180027962, 0.09208238869905472, -0.23081490397453308, -0.10225310176610947, 0.09127605706453323, 0.05773589387536049, -0.17756898701190948, 0.057626765221357346, -0.014421775937080383, 0.11121932417154312, -0.08137132972478867, 0.003927851095795631, 0.05641161650419235], "changes": {"1wk": 1.400003433227539}}, {"text": "Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now? Mashaid Ahmed Mon, Dec 30, 2024, 10:41 PM 6 min read In This Article: ARDX -1.31% We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now . In this article, we are going to take a look at where Ardelyx, Inc. (NASDAQ: ARDX ) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks. In a recent note to clients, John Flood, Goldman\u2019s Head of Americas Equities Sales Trading, highlighted biotech as an under-the-radar opportunity for those seeking to capitalize on the Fed\u2019s rate cuts. Flood noted that biotechnology stocks are uniquely sensitive to changes in interest rates as they often rely on projected future profits and are heavily impacted by the cost of capital. With little or no current profitability but significant upside potential, if clinical trials succeed, these stocks have an \u201coption-like structure\u201d that makes them particularly responsive to interest rate movements. The note also emphasized that biotech has recently seen improved fundamentals driven by positive clinical outcomes and a more favorable regulatory environment. Despite these tailwinds, biotech remains under-owned by hedge funds. According to Goldman\u2019s data, the sector ranks in the 13th percentile in hedge fund long/short positioning over the past year and just the 4th percentile over the past five years. Recent performance data supports Goldman\u2019s outlook. The iShares Biotech ETF climbed 7.7% in Q3, outperforming the Nasdaq Biotech Index and more than doubling the S&P 500\u2019s 3.2% gain over the same period. For investors anticipating a continued decline in bond yields, Goldman suggests biotechnology stocks may offer more attractive exposure compared to other rate-sensitive equity sectors, which are more dependent on broader economic growth trends. READ ALSO: 12 Best Technology Penny Stocks To Buy According to Hedge Funds and 12 Best Energy Stocks To Invest In Now . Biotech Innovations: Small Caps Lead the Way In an interview with Yahoo Finance on October 30, Stacey Sears, Portfolio Manager at Emerald Advisers, provided a comprehensive overview of the current landscape and investment opportunities in small and emerging biotechnology companies. Sears acknowledged that there has been a significant innovation in the healthcare industry, especially over the past 20 to 30 years, which was catalyzed after the decoding of the human genome in 2003, as it identified over 8,000 genetic diseases. This breakthrough provided a roadmap for researchers and scientists, leading to accelerated innovation in areas such as DNA and RNA editing and the development of treatments for orphan and rare diseases. Story Continues Sears noted that small and emerging biotechnology companies have been at the forefront of this innovation. In 2023, approximately two-thirds of all clinical trials were initiated by small and emerging biotechnology firms, and about 56% of new drug substances approved by regulatory bodies originated from these smaller companies. Sears pointed out that the sector has been underperforming over the past couple of years. This underperformance is largely due to the inverse correlation between healthcare stocks and interest rates and yields. However, she noted that the sector is now starting to see a favorable shift. Clinical advancements have continued unabated, and the pipeline of new treatments and drugs remains robust. Large pharmaceutical companies are facing a patent cliff, estimated to be around $30 billion by the end of this decade as their drugs become generic. Small and emerging biotechnology companies are seen as key sources for filling this pipeline. This situation is creating a potential M&A tailwind, as larger companies look to acquire innovative smaller firms to bolster their drug pipelines. The biotechnology sector presents a unique investment opportunity, driven by favorable interest rates, ongoing clinical advancements, and increased M&A activity. Small and emerging biotech firms, in particular, are poised to play a critical role in addressing unmet medical needs and fueling innovation in the healthcare space. Why Ardelyx, Inc. (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now? An aerial view of a pharmaceutical facility, showing the size and scale of the company's operations. Our Methodology To compile our list of the 12 best biotech penny stocks to invest in now, we used Finviz and Yahoo stock screeners to find the 30 largest biotechnology companies trading below the price of $5 as of December 26. We then used Insider Monkey\u2019s Hedge Fund database to rank 12 stocks according to the largest number of hedge fund holders, as of Q3 2024. The list is sorted in ascending order of hedge fund sentiment. Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter\u2019s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). Ardelyx, Inc. (NASDAQ: ARDX ) Number of Hedge Fund Investors: 20 Stock Price as of December 26: $4.64 Ardelyx, Inc. (NASDAQ:ARDX) is a biopharmaceutical company dedicated to developing therapies for kidney and gastrointestinal diseases. The company\u2019s lead product, IBSRELA, is approved for the treatment of irritable bowel syndrome with constipation (IBS-C), while another key candidate, XPHOZAH, addresses hyperphosphatemia in chronic kidney disease patients. Ardelyx, Inc. (NASDAQ:ARDX) is actively expanding its commercial reach to drive market penetration and increase patient access to its therapies. The company recently completed the expansion of its field sales team for IBSRELA, which is expected to significantly enhance its ability to reach and educate healthcare providers about the benefits of IBSRELA. This expanded sales force will also help\u00a0healthcare providers expand their understanding of appropriate IBSRELA patient profiles. Moreover, the company is leveraging key industry conferences to highlight the impact of IBS-C on patients\u2019 lives and the unique benefits of IBSRELA. Ardelyx, Inc. (NASDAQ:ARDX) is committed to expanding its pipeline and exploring strategic partnerships to further enhance its product portfolio. The company is dedicated to developing and in-licensing or acquiring new products that align with its mission to serve patients with gastrointestinal and kidney diseases. Overall, ARDX ranks 11th on our list of best biotech penny stocks to invest in now. While we acknowledge the potential of ARDX to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ARDX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock . Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2024-12-30T19:41:43+00:00", "sentiment": {"score": 0.8826746344566345, "confidence": 0.9206464290618896, "probabilities": {"positive": 0.9206464290618896, "negative": 0.03797179460525513, "neutral": 0.041381701827049255}}, "embedding": [-0.004117632284760475, -0.15090645849704742, -0.02234540320932865, -0.09151777625083923, 0.10052460432052612, -0.08034005016088486, -0.03637376427650452, 0.11748300492763519, 0.13610565662384033, 0.046622879803180695, -0.16928434371948242, 0.23209986090660095, -0.060313425958156586, 0.03778505325317383, -0.09500686824321747, -0.02324722148478031, -0.04263228550553322, -0.02136356383562088, -0.06568020582199097, 0.11604522913694382, -0.048773255199193954, -0.001160303596407175, 0.15568986535072327, -0.011039149016141891, 0.0454665869474411, -0.00880425889045, 0.0446121022105217, -0.08036614954471588, -0.2801629304885864, -0.11333154141902924, 0.007757373619824648, 0.1538236141204834, 0.006172251421958208, -0.12583255767822266, -0.10856647044420242, 0.17122896015644073, -0.005158751271665096, 0.12235594540834427, 0.09196008741855621, -0.04007687419652939, -0.038497649133205414, -0.13952916860580444, -0.07504265010356903, -0.0138038145378232, 0.0560900941491127, -0.19386079907417297, -0.009385391138494015, -0.10479988157749176, 0.0843002125620842, -0.04217648133635521, -0.16766294836997986, -0.13568761944770813, 0.0757109597325325, -0.05421674996614456, -0.05451317876577377, 0.08923439681529999, -0.08732515573501587, -0.0325571671128273, 0.02861008606851101, 0.007960014045238495, 0.15305426716804504, -0.054280735552310944, 0.036996081471443176, -0.006676472257822752, 0.028221312910318375, -0.020639540627598763, 0.041144222021102905, 0.11623219400644302, -0.07241670042276382, 0.025699179619550705, 0.13578903675079346, -0.05577326938509941, -0.16482768952846527, 0.012957793660461903, -0.018413573503494263, 0.09197802096605301, 0.14927458763122559, 0.1309628188610077, 0.2333560287952423, -0.009609959088265896, 0.04254493862390518, -0.024870455265045166, 0.06853169947862625, -0.028818732127547264, -0.06846453249454498, 0.02892426773905754, 0.056242816150188446, 0.02138986438512802, 0.01618800312280655, -0.026520924642682076, 0.08248892426490784, -0.013917630538344383, 0.03244871273636818, -0.006113069131970406, 0.056406520307064056, -0.0504000298678875, -0.09570732712745667, -0.039614059031009674, -0.031395554542541504, -0.04640424996614456, 0.1677505522966385, 0.022175023332238197, -0.08665665984153748, 0.04911418631672859, 0.014980173669755459, -0.18472929298877716, 0.04103013500571251, -0.03211022913455963, 0.1653030514717102, 0.07306791096925735, -0.031138155609369278, 0.20382478833198547, -0.09417607635259628, -0.00025985477259382606, -0.17491497099399567, 0.13964274525642395, -0.052444275468587875, -0.06879639625549316, 0.09897087514400482, 0.0486239418387413, 0.007986238226294518, 0.12430822849273682, -0.10132507979869843, -0.06681567430496216, 0.025664523243904114, 0.0425557903945446, -0.24046379327774048, 9.616392349710812e-33, -0.04719579964876175, 0.13178002834320068, 0.0027105743065476418, -0.09565766155719757, -0.10585819184780121, 0.049163028597831726, 0.033245351165533066, -0.13142360746860504, -0.13288824260234833, -0.09687341749668121, -0.21650223433971405, 0.08383402228355408, -0.05210423842072487, 0.011086815036833286, -0.009287973865866661, -0.16742172837257385, -0.11227608472108841, 0.07935185730457306, 0.0418979786336422, -0.04867929965257645, -0.10916321724653244, 0.12866534292697906, -0.08399170637130737, 0.06494218111038208, 0.01823624223470688, -0.17600108683109283, -0.06621520221233368, -0.01954914629459381, 0.03438817709684372, 0.08918419480323792, -0.05781200900673866, 0.05068712681531906, -0.04313924163579941, -0.09953419864177704, -0.024353425949811935, -0.00945313274860382, -0.05330939590930939, -0.08084272593259811, 0.06962757557630539, 0.09166499972343445, -0.10439344495534897, 0.2051895558834076, -0.045753899961709976, -0.09047120064496994, -0.015090064145624638, 0.049818284809589386, -0.01558239571750164, 0.08166749775409698, -0.12218143790960312, -0.006610766518861055, -0.15133659541606903, 0.08115404844284058, 0.08687977492809296, -0.07607647776603699, 0.04261353984475136, 0.0033991215750575066, -0.13201412558555603, -0.10499393939971924, -0.058913130313158035, 0.10348707437515259, 0.08034326136112213, 0.0948859453201294, -0.05343746021389961, 0.11581824719905853, -0.2064916491508484, 0.21483390033245087, 0.11004168540239334, 0.08220650255680084, -0.15190497040748596, 0.31797927618026733, -0.017032837495207787, -0.029641421511769295, -0.010505959391593933, -0.04806807264685631, 0.033035386353731155, -0.11475943773984909, -0.08534170687198639, 0.0322829894721508, 0.031257759779691696, 0.06310437619686127, 0.08490459620952606, -0.041072115302085876, -0.12980002164840698, 0.06030206382274628, -0.01679941639304161, -0.009731428697705269, 0.0017022783868014812, 0.024990510195493698, 0.08009285479784012, -0.004063582979142666, -0.029463965445756912, -0.060201868414878845, -0.046772100031375885, 0.11103139817714691, 0.024946656078100204, -1.0494892910010063e-32, -0.004519973881542683, -0.12711705267429352, 0.07651975750923157, 0.08132682740688324, -0.02075979858636856, 0.09119724482297897, 0.15128640830516815, -0.09683020412921906, 0.0440802238881588, -0.14426517486572266, -0.01991422474384308, 0.17988011240959167, -0.08625611662864685, -0.0028969855047762394, -0.06615467369556427, -0.0034545809030532837, -0.07636979222297668, -0.11831344664096832, 0.047391679137945175, -0.037474848330020905, -0.004208693280816078, 0.14747901260852814, -0.1556413471698761, 0.10512936115264893, -0.08204881846904755, 0.08742130547761917, -0.150466650724411, 0.1087714284658432, 0.022808048874139786, -0.08663080632686615, -0.06395735591650009, 0.005174162797629833, -0.18703679740428925, 0.13854798674583435, -0.04650484025478363, 0.08902974426746368, 0.07356250286102295, -0.1360846310853958, -0.03212396800518036, -0.004965539090335369, 0.07643558830022812, 0.009564911015331745, -0.00846240296959877, 0.021849054843187332, 0.09413320571184158, 0.02836061641573906, 0.023816999047994614, 0.0938541442155838, 0.126447856426239, 0.047151997685432434, -0.01360420510172844, 0.04993315786123276, 0.1202133297920227, 0.040749162435531616, -0.09715255349874496, -0.09622407704591751, 0.04326409101486206, 0.04866936430335045, -0.0287456177175045, 0.09514596313238144, -0.06766579300165176, 0.11656448990106583, 0.04320405423641205, 0.020396066829562187, -0.10205420851707458, -0.01820915751159191, 0.0044043418020009995, 0.009038129821419716, -0.10013042390346527, -0.12001843750476837, 0.05707332119345665, -0.0339968204498291, 0.06860058754682541, -0.05482473969459534, -0.053055666387081146, 0.25748735666275024, -0.05154968425631523, -0.11638329923152924, -0.15028908848762512, 0.07326371222734451, 0.10535675287246704, 0.046431414783000946, 0.054147493094205856, 0.01941237971186638, -0.02089310809969902, 0.2346406877040863, 0.0464368499815464, -0.07118238508701324, -0.12946003675460815, -0.06711553037166595, -0.0812762975692749, -0.1370752602815628, -0.04797247424721718, 0.08414576947689056, -0.017510827630758286, -1.0011530804376889e-07, 0.11955799162387848, -0.1535232812166214, 0.008222365751862526, -0.1474427729845047, 0.022335967049002647, 0.018019691109657288, -0.02120038866996765, 0.11908094584941864, 0.15389558672904968, 0.1654086410999298, 0.09374770522117615, 0.23461909592151642, -0.1953025460243225, 0.1233506053686142, -0.062036965042352676, 0.007013975642621517, -0.09009511768817902, -0.0010028299875557423, -0.015483148396015167, -0.010348696261644363, -0.050061170011758804, 0.1450946033000946, -0.009756268002092838, -0.05267210304737091, 0.09725579619407654, -0.09200256317853928, 0.04453350603580475, -0.04310286045074463, 0.013383878394961357, 0.02058425173163414, -0.0037684189155697823, -0.010901128873229027, 0.023625383153557777, 0.08653741329908371, -0.036639388650655746, -0.031492676585912704, 0.08441227674484253, 0.059032976627349854, 0.09475119411945343, 0.051429037004709244, -0.03140687197446823, -0.04118617624044418, -0.1262868344783783, -0.08147655427455902, -0.03323300927877426, -0.09800967574119568, -0.06280885636806488, 0.009206084534525871, 0.10989207774400711, -0.1600150763988495, 0.018733689561486244, -0.07259867340326309, 0.1167466938495636, -0.01734384149312973, 0.008418628945946693, 0.12642574310302734, -0.16462279856204987, -0.042161330580711365, -0.08064166456460953, -0.05737332999706268, 0.11522503197193146, -0.24401846528053284, 0.15700283646583557, 0.09138818085193634], "changes": {"1wk": -4.761904761904762, "1mo": 4.3809527442568825}}, {"text": "Exploring 3 High Growth Tech Stocks in the United States editorial-team@simplywallst.com (Simply Wall St) Mon, Dec 30, 2024, 5:08 PM 4 Minuten Lesezeit In diesem Artikel: ARDX -1.31% VNET +3.59% GDYN +0.75% In the last week, the United States market has been flat yet it has shown a robust 24% increase over the past year with earnings expected to grow by 15% annually in the coming years. In this dynamic environment, identifying high growth tech stocks that align with these optimistic projections can be crucial for investors seeking opportunities in sectors poised for expansion. Top 10 High Growth Tech Companies In The United States Name Revenue Growth Earnings Growth Growth Rating Super Micro Computer 24.13% 24.28% \u2605\u2605\u2605\u2605\u2605\u2605 Ardelyx 25.47% 69.63% \u2605\u2605\u2605\u2605\u2605\u2605 Sarepta Therapeutics 24.07% 43.17% \u2605\u2605\u2605\u2605\u2605\u2605 Alnylam Pharmaceuticals 22.34% 70.30% \u2605\u2605\u2605\u2605\u2605\u2605 Clene 77.61% 59.19% \u2605\u2605\u2605\u2605\u2605\u2605 TG Therapeutics 34.86% 56.98% \u2605\u2605\u2605\u2605\u2605\u2605 Alkami Technology 21.99% 102.65% \u2605\u2605\u2605\u2605\u2605\u2605 Travere Therapeutics 31.70% 72.51% \u2605\u2605\u2605\u2605\u2605\u2605 Seagen 22.57% 71.80% \u2605\u2605\u2605\u2605\u2605\u2605 ImmunoGen 26.00% 45.85% \u2605\u2605\u2605\u2605\u2605\u2605 Click here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener. Let's explore several standout options from the results in the screener. Grid Dynamics Holdings Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2606\u2606 Overview: Grid Dynamics Holdings, Inc. offers technology consulting, platform and product engineering, and analytics services across North America, Europe, and internationally with a market cap of approximately $1.89 billion. Operations: Specializing in computer services, Grid Dynamics Holdings generates revenue of $328.36 million through its technology consulting and engineering solutions across various regions. Grid Dynamics Holdings, Inc. (GDYN) has demonstrated robust growth with a notable 17% annual revenue increase and an impressive 81.3% forecasted annual earnings growth, outpacing the US market averages of 9.2% and 15.3%, respectively. Recently, the firm launched a developer portal to enhance software lifecycle management, reflecting its commitment to innovation in tech solutions. This move aligns with industry trends towards streamlined development processes and could significantly boost client productivity and project management efficiency. Despite some challenges like a one-off loss of $4.2 million affecting recent financial results, GDYN's strategic initiatives suggest strong future prospects in high-tech environments. Click here and access our complete health analysis report to understand the dynamics of Grid Dynamics Holdings. Understand Grid Dynamics Holdings' track record by examining our Past report. NasdaqCM:GDYN Revenue and Expenses Breakdown as at Dec 2024 Ardelyx Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas in the United States and internationally, with a market cap of $1.23 billion. Weiterlesen Operations: The company generates revenue primarily from the development and commercialization of biopharmaceutical products, amounting to $251.85 million. Its operations are centered on addressing gastrointestinal and cardiorenal health issues, catering to both domestic and international markets. Ardelyx, Inc. has been navigating a transformative phase with substantial revenue growth reported at 25.5% annually, significantly outpacing the broader US market average of 9.2%. This surge is primarily driven by innovative treatments like XPHOZAH\u00ae, a pioneering phosphate absorption inhibitor for kidney disease patients, underscoring Ardelyx's commitment to addressing complex medical needs through distinct mechanisms of action. Despite facing challenges such as a recent net loss of $43.78 million and share dilution over the past year, the company's strategic presentations at major healthcare conferences and robust pipeline developments signal strong potential for future profitability and market influence in biotechnology, particularly as it moves towards an anticipated profit growth rate of 69.63% annually within three years. Click here to discover the nuances of Ardelyx with our detailed analytical health report. Evaluate Ardelyx's historical performance by accessing our past performance report. NasdaqGM:ARDX Earnings and Revenue Growth as at Dec 2024 VNET Group Simply Wall St Growth Rating: \u2605\u2605\u2605\u2605\u2606\u2606 Overview: VNET Group, Inc. is an investment holding company that offers hosting and related services in China, with a market capitalization of $1.14 billion. Operations: The company generates revenue primarily from hosting and related services, amounting to CN\u00a57.91 billion. VNET Group's recent strategic alliance to form a pre-REITs fund targeting hyperscale data centers in China underscores its innovative approach to capitalizing on infrastructure growth, with an initial investment valued at approximately $828.3 million. This move complements their robust Q3 earnings, where sales rose to CNY 2.12 billion, up from CNY 1.89 billion year-over-year, and net income turned positive at CNY 317.63 million compared to a loss previously. The company has raised its full-year revenue guidance by up to 9.3%, reflecting confidence in sustained growth amidst volatile market conditions. Navigate through the intricacies of VNET Group with our comprehensive health report here. Explore historical data to track VNET Group's performance over time in our Past section. NasdaqGS:VNET Earnings and Revenue Growth as at Dec 2024 Where To Now? Gain an insight into the universe of 236 US High Growth Tech and AI Stocks by clicking here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St , where you can monitor all the vital signs of your stocks effortlessly. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management . Find companies with promising cash flow potential yet trading below their fair value . This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqCM:GDYN NasdaqGM:ARDX and NasdaqGS:VNET . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com Kommentare anzeigen AGB und Datenschutzerkl\u00e4rung Privacy Dashboard Empfohlene Nachrichtenartikel", "symbol": "ARDX", "date": "2024-12-30T14:08:39+00:00", "sentiment": {"score": 0.6073203571140766, "confidence": 0.6189717054367065, "probabilities": {"positive": 0.6189717054367065, "negative": 0.011651348322629929, "neutral": 0.3693769574165344}}, "embedding": [-0.05193275213241577, -0.12425518780946732, -0.08179643750190735, -0.03156641125679016, 0.008587483316659927, -0.0752030536532402, 0.01007894054055214, 0.07593892514705658, 0.09915189445018768, 0.06242157518863678, -0.08538943529129028, 0.1521880328655243, 0.023071587085723877, -0.010478254407644272, -0.09413959830999374, -0.018020376563072205, 0.011574420146644115, -0.10517874360084534, 0.02243289165198803, -0.0031142886728048325, 0.009367356076836586, -0.07345768064260483, -0.023833440616726875, -0.07917829602956772, 0.1383039802312851, 0.02437995746731758, -0.10748155415058136, 0.07450844347476959, -0.15156929194927216, -0.07568655163049698, -0.055196162313222885, 0.10101012140512466, 0.004933197516947985, 0.00015054643154144287, -0.008603840135037899, 0.011714667081832886, -0.03192354366183281, 0.03059403970837593, 0.01755513623356819, -0.009155435487627983, 0.016498880460858345, -0.048174094408750534, -0.047253452241420746, 0.003861094359308481, -0.005734787322580814, -0.10378971695899963, -0.04145753011107445, 0.025163857266306877, 0.0011792168952524662, 0.06172199547290802, -0.12445158511400223, -0.1066819280385971, 0.07388806343078613, 0.031030820682644844, -0.016720987856388092, 0.012162419967353344, -0.11927755922079086, 0.004076460376381874, 0.12026819586753845, -0.11144864559173584, 0.08289410918951035, -0.0742596983909607, -0.0074751595966517925, -0.023884879425168037, 0.046616263687610626, 0.0179066751152277, -0.027563557028770447, 0.11301398277282715, -0.08722114562988281, -0.0905914381146431, 0.14038054645061493, -0.04946328327059746, -0.15574103593826294, -0.02188400737941265, -0.07934823632240295, 0.12261877954006195, 0.10563132166862488, 0.037563733756542206, 0.1755692958831787, -0.05908939614892006, 0.03930925577878952, 0.046812016516923904, -0.045901745557785034, 0.042140401899814606, -0.1484682857990265, 0.03283759579062462, 0.04239679127931595, 0.09471410512924194, 0.15207086503505707, -0.061241116374731064, 0.06874039769172668, 0.05436108261346817, -0.02184133045375347, 0.04544691741466522, 0.01732834428548813, 0.07231126725673676, -0.08380961418151855, -0.1387203335762024, -0.05009835958480835, 0.04106352478265762, 0.0840095728635788, -0.02636726386845112, 0.07243102788925171, 0.012347660958766937, -0.10242396593093872, -0.08417925238609314, 0.0808502659201622, 0.08995712548494339, 0.023851217702031136, -0.00927063636481762, -0.07545366883277893, 0.09374749660491943, -0.17619243264198303, -0.054814305156469345, -0.056228190660476685, 0.0013104043900966644, -0.05214724689722061, 0.007896505296230316, 0.1432795524597168, -0.06728125363588333, 0.09508433938026428, 0.07911191880702972, -0.07971031963825226, -0.025225603953003883, 0.004722959361970425, 0.05536341667175293, -0.11601007729768753, 1.5186589145833334e-32, -0.037426985800266266, 0.10093030333518982, -0.04136952757835388, 0.03215501829981804, -0.018011268228292465, -0.006234022323042154, 0.043639883399009705, -0.050124943256378174, -0.06872624158859253, 0.01786181703209877, -0.26713335514068604, 0.21528781950473785, -0.053770117461681366, 0.10757863521575928, 0.10769981145858765, -0.1521396040916443, 0.06337793916463852, 0.07606914639472961, 0.037867020815610886, -0.06101313978433609, 0.04959775507450104, 0.09688982367515564, 0.012613765895366669, -0.0321185365319252, 0.04846935346722603, -0.03819620609283447, -0.1157163754105568, -0.01739165373146534, -0.06899303942918777, 0.04555721580982208, 0.008032958023250103, -0.009534106589853764, -0.035538822412490845, -0.08482682704925537, -0.015056027099490166, -0.06583438813686371, -0.0888388454914093, -0.10660503059625626, 0.09016212075948715, 0.004295530263334513, -0.12547220289707184, 0.08313801884651184, -0.15173909068107605, -0.04262677952647209, 0.012681746855378151, 0.08230313658714294, -0.008199475705623627, -0.015880431979894638, 0.00017260387539863586, -0.04179683327674866, -0.04887419193983078, 0.08699364215135574, -0.014927656389772892, -0.01842690445482731, -0.005006581544876099, 0.1021474152803421, 0.004773683845996857, -0.0314447246491909, 0.16267530620098114, 0.09760425984859467, -0.09277497977018356, 0.03111371025443077, 0.042962756007909775, -0.0029871100559830666, -0.042736321687698364, 0.10547701269388199, 0.10632011294364929, 0.10942807048559189, 0.005578174255788326, 0.21418076753616333, 0.05640709400177002, -0.1349441260099411, 0.16124111413955688, 0.006940145045518875, 0.148175910115242, -0.012505680322647095, -0.05225607007741928, 0.06644786894321442, -0.09210536628961563, 0.0373014397919178, -0.12973162531852722, 0.008988680317997932, -0.10942663252353668, 0.02466425485908985, -0.022779414430260658, -0.0017794722225517035, 0.03427121043205261, 0.01850358583033085, -0.018344668671488762, -0.06896858662366867, -0.04810601472854614, -0.11879871785640717, 0.06754966080188751, 0.10625153034925461, -0.11376922577619553, -1.6009026707122024e-32, -0.09524184465408325, -0.0615350604057312, 0.01820012927055359, -0.06882406771183014, -0.02583296224474907, 0.03174632787704468, 0.05182003974914551, 0.012582475319504738, -0.050868161022663116, -0.0657871887087822, -0.011882584542036057, 0.13495966792106628, -0.08710599690675735, 0.05224462226033211, -0.0027049968484789133, 0.013999393209815025, 0.017644651234149933, -0.09425076842308044, 0.036768101155757904, -0.04742322489619255, 0.03245283663272858, 0.0650676041841507, -0.19398750364780426, 0.14449752867221832, 0.13469165563583374, 0.03435125946998596, -0.014918005093932152, 0.07426474988460541, -0.007393535226583481, 0.10745412856340408, -0.09780029952526093, 0.012293849140405655, -0.10422632098197937, 0.13272416591644287, 0.07084180414676666, 0.0850948691368103, 0.024391138926148415, -0.09173085540533066, -0.017369525507092476, -0.07856839150190353, 0.07929365336894989, -0.06141764298081398, 0.05867665261030197, 0.13499456644058228, 0.03936183452606201, 0.03783857449889183, 0.03044058196246624, 0.0648176521062851, 0.0618651807308197, 0.021391835063695908, -0.007936711423099041, 0.11088742315769196, -0.023437464609742165, 0.09278113394975662, -0.08701685816049576, -0.007624736987054348, 0.03314576670527458, 0.11077487468719482, -0.17927677929401398, -0.06712250411510468, -0.0013894934672862291, 0.048713319003582, 0.0013531269505620003, 0.10112085938453674, -0.028680650517344475, 0.02579648233950138, 0.009163932874798775, -0.11792734265327454, -0.04696088284254074, -0.179024338722229, 0.019636690616607666, -0.030998388305306435, 0.01638314314186573, -0.13452696800231934, -0.06958061456680298, 0.10959227383136749, 0.12213705480098724, -0.05317603051662445, -0.03359753265976906, 0.04498015344142914, -0.0038217364344745874, 0.11274583637714386, 0.024755721911787987, 0.0020065931603312492, -0.10500308871269226, 0.08214026689529419, -0.055876474827528, -0.09380224347114563, -0.040495604276657104, -0.012707489542663097, -0.07842545211315155, -0.13509410619735718, -0.12480708956718445, -0.021277712658047676, -0.039488647133111954, -1.0077987155909796e-07, -0.023010902106761932, 0.03026735410094261, 0.122179314494133, -0.07624328881502151, 0.08997339755296707, -0.04427483677864075, 0.06729824841022491, 0.11698347330093384, 0.03815367445349693, 0.13315019011497498, 0.12418264895677567, -0.08195102214813232, -0.09266377985477448, -0.0749913901090622, -0.05349655821919441, 0.009710773825645447, -0.09426791965961456, 0.10884326696395874, -0.08472036570310593, -0.07215756177902222, 0.07075658440589905, 0.10047371685504913, 0.11836735904216766, -0.027435701340436935, 0.055050306022167206, -0.07305543124675751, -0.10797499120235443, -0.14783933758735657, 0.015544921159744263, 0.08557780086994171, 0.11441867053508759, -0.03659619390964508, 0.15660154819488525, -0.019245300441980362, 0.07942407578229904, 0.022772913798689842, 0.01041024923324585, 0.05462417006492615, 0.08762884885072708, -0.031362831592559814, -0.0861133262515068, -0.06400617957115173, 0.09798318147659302, -0.08610282838344574, -0.11601755023002625, -0.10659615695476532, -0.1942424476146698, -0.022568844258785248, 0.15046261250972748, -0.13801300525665283, 0.042799968272447586, -0.12625890970230103, -0.0292626041918993, 0.0046386863104999065, -0.009301412850618362, 0.016672443598508835, -0.13603320717811584, -0.041003912687301636, -0.00924968346953392, -0.011705154553055763, 0.1010255366563797, -0.2109302282333374, 0.020193446427583694, 0.1040228009223938], "changes": {"1wk": -5.333337329682849, "1mo": 4.571424211774554}}, {"text": "Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? editorial-team@simplywallst.com (Simply Wall St) Mon, Dec 16, 2024, 9:33 PM 3 min read In This Article: ARDX -1.31% We feel now is a pretty good time to analyse Ardelyx, Inc.'s ( NASDAQ:ARDX ) business as it appears the company may be on the cusp of a considerable accomplishment. Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company\u2019s loss has recently broadened since it announced a US$66m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$73m, moving it further away from breakeven. Many investors are wondering about the rate at which Ardelyx will turn a profit, with the big question being \u201cwhen will the company breakeven?\u201d We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate. Check out our latest analysis for Ardelyx Consensus from 10 of the American Biotechs analysts is that Ardelyx is on the verge of breakeven. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$113m in 2026. The company is therefore projected to breakeven around 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 70% is expected, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. NasdaqGM:ARDX Earnings Per Share Growth December 16th 2024 Underlying developments driving Ardelyx's growth isn\u2019t the focus of this broad overview, though, keep in mind that by and large biotechs, depending on the stage of product development, have irregular periods of cash flow. So, a high growth rate is not out of the ordinary, particularly when a company is in a period of investment. Before we wrap up, there\u2019s one issue worth mentioning. Ardelyx currently has a relatively high level of debt. Generally, the rule of thumb is debt shouldn\u2019t exceed 40% of your equity, which in Ardelyx's case is 79%. A higher level of debt requires more stringent capital management which increases the risk around investing in the loss-making company. Next Steps: This article is not intended to be a comprehensive analysis on Ardelyx, so if you are interested in understanding the company at a deeper level, take a look at Ardelyx's company page on Simply Wall St . We've also put together a list of pertinent factors you should further research: Valuation : What is Ardelyx worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Ardelyx is currently mispriced by the market. Management Team : An experienced management team on the helm increases our confidence in the business \u2013 take a look at who sits on Ardelyx\u2019s board and the CEO\u2019s background . Other High-Performing Stocks : Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2024-12-16T18:33:26+00:00", "sentiment": {"score": -0.08745965361595154, "confidence": 0.26064828038215637, "probabilities": {"positive": 0.17318862676620483, "negative": 0.26064828038215637, "neutral": 0.5661630630493164}}, "embedding": [-0.02856328710913658, -0.12310756742954254, -0.03899729996919632, -0.004940899088978767, 0.019417576491832733, -0.10745348781347275, 0.00561592448502779, 0.11650042235851288, 0.07894378900527954, 0.10367628931999207, -0.10539798438549042, 0.1379392445087433, -0.023255782201886177, 0.04238496720790863, -0.1466693878173828, -0.01794600859284401, -0.09125065058469772, -0.12281020730733871, -0.1179208979010582, 0.10550535470247269, 0.05336517095565796, -0.07825063914060593, -0.0017162100411951542, -0.004316477570682764, 0.07454203069210052, -0.09113914519548416, 0.07693029940128326, -0.017827099189162254, -0.15497924387454987, -0.05651438236236572, -0.022586267441511154, 0.1429978609085083, 0.09372344613075256, -0.0626576840877533, -0.037249572575092316, 0.037309251725673676, -0.125063955783844, 0.0702446699142456, 0.0003028525970876217, 0.029095470905303955, -0.03209667280316353, -0.07748978585004807, -0.08865204453468323, 0.03899010643362999, -0.007371802814304829, -0.1901254653930664, 0.011912694200873375, 0.04780464619398117, -0.006002569571137428, 0.12525762617588043, -0.19698971509933472, -0.08925877511501312, 0.04659228026866913, -0.004926684312522411, 0.016598278656601906, 0.010896795429289341, -0.13820043206214905, -0.1785351186990738, 0.0021937203127890825, -0.031224874779582024, 0.08129674196243286, 0.0352344736456871, -0.034735649824142456, -0.02827160805463791, 0.13772881031036377, -0.02107013203203678, 0.10866387188434601, 0.047790005803108215, -0.14677272737026215, 0.09477188438177109, 0.09394766390323639, -0.12620896100997925, -0.1790248155593872, -0.05597589910030365, -0.03255598619580269, 0.08103384077548981, 0.10675446689128876, 0.043035805225372314, 0.10970425605773926, -0.08622491359710693, 0.12410732358694077, 0.07537683099508286, 0.018352901563048363, -0.15162301063537598, -0.08442340046167374, 0.025502517819404602, 0.1380234658718109, 0.06595443934202194, 0.14944840967655182, -0.03211016207933426, 0.06112498790025711, 0.008974490687251091, -0.0422830656170845, 0.00038091075839474797, 0.14433884620666504, 0.0805910974740982, -0.08467254042625427, -0.09216949343681335, 0.014699014835059643, -0.009623151272535324, 0.08504657447338104, 0.05762474983930588, -0.018969839438796043, -0.07540804147720337, 0.0007884707301855087, -0.15722748637199402, 0.061893559992313385, 0.05342447757720947, 0.035450659692287445, 0.07046140730381012, -0.045195549726486206, 0.08010907471179962, -0.055463630706071854, -0.014195590279996395, -0.05659893900156021, 0.12415751814842224, -0.05480864644050598, -0.03214265778660774, 0.02564498782157898, -0.0016979100182652473, 0.012100480496883392, 0.1860109269618988, -0.04738326370716095, -0.003921485505998135, 0.00019370485097169876, 0.0679636299610138, -0.18177634477615356, 1.0245429498878558e-32, -0.1147494837641716, -0.005621196702122688, -0.037396300584077835, -0.01109982654452324, -0.0835377648472786, 0.01591147482395172, 0.0025677247904241085, -0.010494738817214966, 0.01911614090204239, -0.07958938181400299, -0.227493017911911, -0.026341263204813004, -0.02788466587662697, -0.01720462739467621, 0.11690890789031982, -0.09009262919425964, 0.028874078765511513, 0.10132850706577301, 0.0019874584395438433, -0.035495683550834656, -0.0208244938403368, -0.01330531109124422, -0.0769515186548233, 0.017869943752884865, 0.01789657026529312, -0.025601351633667946, -0.032753653824329376, -0.011427437886595726, -0.05556907877326012, 0.04707985743880272, 0.10770253092050552, 0.01743350178003311, -0.08064725995063782, -0.10383085906505585, -0.09712506830692291, -0.05441086366772652, -0.13903819024562836, 0.013306733220815659, 0.05943631753325462, 0.05889420211315155, -0.20446987450122833, 0.08272809535264969, -0.10074711591005325, -0.024612490087747574, 0.037151601165533066, -0.05935464799404144, -0.01919054612517357, 0.036450956016778946, -0.03963574022054672, -0.038448359817266464, 0.008312682621181011, 0.012525497935712337, 0.06459635496139526, -0.0732804462313652, 0.03579014539718628, 0.1092538982629776, -0.028530476614832878, -0.10959234088659286, 0.09267616271972656, 0.1131773367524147, -0.030566122382879257, 0.148086279630661, 0.04120805859565735, 0.03794799745082855, -0.22154420614242554, 0.20519700646400452, 0.05458708852529526, 0.021971607580780983, 0.0030196718871593475, 0.16643500328063965, 0.023765191435813904, -0.046067968010902405, 0.062205083668231964, -0.16822806000709534, 0.09280085563659668, -0.04704821854829788, 0.015031063929200172, 0.024962056428194046, 0.10624003410339355, 0.08001306653022766, -0.06033342704176903, 0.000889897346496582, 0.021984847262501717, -0.033886317163705826, 0.016529779881238937, -0.03900987282395363, 0.04889979958534241, 0.03488468378782272, -0.00600731186568737, 0.060581907629966736, 0.024577602744102478, -0.03366001695394516, -0.056275736540555954, 0.1671697199344635, 0.09431661665439606, -1.0816508164395041e-32, 0.024286124855279922, -0.04390575736761093, 0.014204498380422592, -0.024148516356945038, 0.009709447622299194, -0.0036973212845623493, 0.02302904799580574, 0.06199163943529129, -0.04053955525159836, -0.11240807920694351, -0.014243250712752342, 0.15390166640281677, -0.08440336585044861, 0.09333989024162292, -0.05279180407524109, -0.04915718734264374, 0.1967146098613739, -0.11420514434576035, -0.029477059841156006, -0.027229657396674156, -0.06681084632873535, 0.07409758120775223, -0.1920275092124939, 0.020054098218679428, 0.01172935776412487, 0.0737004280090332, 0.029445424675941467, 0.04884786531329155, -0.05218498036265373, -0.07497747242450714, -0.13770028948783875, 0.012652826495468616, -0.19251611828804016, 0.17338114976882935, -0.01663096994161606, 0.07289692759513855, 0.04573943093419075, -0.11632663756608963, -0.07209382206201553, -0.11049836874008179, 0.1269625574350357, 0.022420872002840042, -0.001676342450082302, 0.01815975457429886, 0.10139305889606476, -0.0859203040599823, 0.13570508360862732, -0.03132614120841026, 0.21727529168128967, -0.003403877839446068, 0.1034441739320755, -0.01780559867620468, 0.13440588116645813, 0.06481576710939407, -0.09625954926013947, 0.049719370901584625, 0.02554791048169136, -0.0782540887594223, -0.06741407513618469, 0.042733725160360336, -0.0416368767619133, 0.10374792665243149, 0.08272751420736313, 0.10212798416614532, 0.010305989533662796, -0.04094948619604111, 0.009658321738243103, -0.1077524870634079, 0.027257129549980164, -0.12043547630310059, 0.04584978148341179, 0.05258503183722496, -0.05807950720191002, 0.017745746299624443, -0.011692099273204803, 0.19092059135437012, 0.0029332684352993965, -0.12825465202331543, -0.05011792480945587, -0.038677603006362915, 0.04540480300784111, 0.0718943178653717, -0.025246672332286835, 0.03239280730485916, -0.13170887529850006, -0.06172649562358856, 0.062166936695575714, -0.05335601419210434, -0.07188617438077927, -0.006154711823910475, -0.1363683044910431, -0.11157292872667313, -0.11289294809103012, -0.07121706008911133, 0.10915052145719528, -1.0067563493976195e-07, 0.04575736075639725, 0.0020416388288140297, 0.03131327033042908, -0.07144010066986084, 0.1841811239719391, -0.07313257455825806, -0.004492462612688541, 0.04936831444501877, 0.10677390545606613, 0.12907685339450836, 0.10099393129348755, 0.16454006731510162, -0.06861872971057892, 0.13714107871055603, -0.11954565346240997, -0.007496977224946022, -0.06425288319587708, 0.02037404663860798, -0.0874241292476654, -0.1301082968711853, 0.002195479813963175, 0.10809276252985, 0.03719913959503174, -0.019757382571697235, 0.040933459997177124, -0.08565956354141235, 0.0033002160489559174, 0.049089621752500534, -0.12810049951076508, 0.009923545643687248, 0.04588735103607178, -0.014414288103580475, 0.005051093176007271, 0.08687075972557068, -0.024018578231334686, -0.06371407955884933, 0.07072004675865173, 0.05791265517473221, 0.10566812008619308, 0.021614238619804382, -0.05016147717833519, 0.013954706490039825, 0.05843491107225418, -0.07611021399497986, -0.0572897233068943, -0.14210346341133118, -0.10420718789100647, -0.02253071963787079, 0.04720441251993179, -0.14032989740371704, 0.12353713810443878, -0.08523223549127579, 0.07679960131645203, -0.00950319692492485, 0.12977242469787598, -0.004885402973741293, -0.09666275233030319, -0.044264692813158035, -0.15147879719734192, 0.026583045721054077, 0.0883280336856842, -0.162923663854599, 0.042128823697566986, 0.1384039968252182], "changes": {"1wk": -15.027828624190295, "1mo": -0.7421143384760089}}, {"text": "US Penny Stocks To Watch In December 2024 editorial-team@simplywallst.com (Simply Wall St) Fri, Dec 27, 2024, 8:09 PM 4 Minuten Lesezeit In diesem Artikel: ARDX -1.31% TALK +1.94% TALKW +6.46% YSG +2.21% As the U.S. stock market experiences a downturn, with major indices like the Dow Jones, S&P 500, and Nasdaq Composite facing declines led by large-cap tech stocks such as Nvidia and Tesla, investors are keenly observing alternative opportunities. Despite their vintage name, penny stocks remain an intriguing investment area for those interested in smaller or newer companies that may offer surprising value. By focusing on penny stocks with robust financials and clear growth potential, investors can potentially uncover promising opportunities in this often-overlooked segment of the market. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating Inter & Co (NasdaqGS:INTR) $4.30 $1.85B \u2605\u2605\u2605\u2605\u2606\u2606 QuantaSing Group (NasdaqGM:QSG) $3.08 $103.25M \u2605\u2605\u2605\u2605\u2605\u2605 BAB (OTCPK:BABB) $0.84 $6.43M \u2605\u2605\u2605\u2605\u2605\u2605 Pangaea Logistics Solutions (NasdaqCM:PANL) $4.90 $234.98M \u2605\u2605\u2605\u2605\u2605\u2606 ZTEST Electronics (OTCPK:ZTST.F) $0.25 $8.83M \u2605\u2605\u2605\u2605\u2605\u2605 Imperial Petroleum (NasdaqCM:IMPP) $2.85 $86.14M \u2605\u2605\u2605\u2605\u2605\u2605 Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M \u2605\u2605\u2605\u2605\u2605\u2605 BTCS (NasdaqCM:BTCS) $2.59 $49.54M \u2605\u2605\u2605\u2605\u2605\u2605 Smith Micro Software (NasdaqCM:SMSI) $1.62 $22.53M \u2605\u2605\u2605\u2605\u2605\u2606 CBAK Energy Technology (NasdaqCM:CBAT) $0.9125 $76.47M \u2605\u2605\u2605\u2605\u2605\u2606 Click here to see the full list of 732 stocks from our US Penny Stocks screener. Let's explore several standout options from the results in the screener. Talkspace Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Talkspace, Inc. is a virtual behavioral healthcare company operating in the United States with a market capitalization of $510.15 million. Operations: The company generates revenue from its Pharmacy Services segment, totaling $181.29 million. Market Cap: $510.15M Talkspace, Inc., with a market cap of US$510.15 million, is making strides in the virtual behavioral healthcare space despite being unprofitable. The company has reduced losses over five years and maintains a strong cash runway exceeding three years due to positive free cash flow. Recent strategic partnerships, such as with Espresa and Wisdo Health, enhance its service offerings and accessibility for workplace wellness and senior mental health care. Talkspace's revenue grew to US$47.4 million in Q3 2024 from US$38.65 million the previous year, marking significant progress towards profitability while trading below estimated fair value by 79.6%. Click here to discover the nuances of Talkspace with our detailed analytical financial health report. Review our growth performance report to gain insights into Talkspace's future. NasdaqCM:TALK Financial Position Analysis as at Dec 2024 Ardelyx Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2606 Overview: Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal conditions, with a market cap of approximately $1.10 billion. Weiterlesen Operations: The company's revenue segment is primarily derived from the development and commercialization of biopharmaceutical products, totaling $251.85 million. Market Cap: $1.1B Ardelyx, Inc., with a market cap of US$1.10 billion, remains unprofitable but has shown progress by reducing losses at 10.5% annually over five years. The company is trading at 93% below its estimated fair value and benefits from a reduced debt-to-equity ratio, now at 79%. Ardelyx's recent earnings report highlighted revenue growth to US$98.24 million in Q3 2024 from US$56.39 million the previous year, despite a net loss of US$0.809 million for the quarter. XPHOZAH\u00ae, approved for chronic kidney disease patients on dialysis, represents significant potential within its product pipeline amidst ongoing volatility in share price and shareholder dilution concerns. Dive into the specifics of Ardelyx here with our thorough balance sheet health report. Examine Ardelyx's earnings growth report to understand how analysts expect it to perform. NasdaqGM:ARDX Financial Position Analysis as at Dec 2024 Yatsen Holding Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2606\u2606 Overview: Yatsen Holding Limited, with a market cap of $462.24 million, develops and sells beauty products in China under various brands including Perfect Diary and Little Ondine. Operations: The company generates CN\u00a53.32 billion in revenue from its operations within the People's Republic of China. Market Cap: $462.24M Yatsen Holding Limited, with a market cap of $462.24 million, remains unprofitable but has managed to reduce its losses by 22.9% annually over the past five years. The company's short-term assets of CN\u00a52.4 billion comfortably cover both its short-term and long-term liabilities, and it is debt-free. Recent earnings showed a decrease in sales to CN\u00a5677.02 million for Q3 2024 from CN\u00a5718.13 million the previous year, though net loss improved to CN\u00a5121.07 million from CN\u00a5196.54 million year-over-year. Financial guidance anticipates stable revenue growth for Q4 2024 amidst executive changes and ongoing operational challenges. Navigate through the intricacies of Yatsen Holding with our comprehensive balance sheet health report here. Explore Yatsen Holding's analyst forecasts in our growth report. NYSE:YSG Debt to Equity History and Analysis as at Dec 2024 Summing It All Up Embark on your investment journey to our 732 US Penny Stocks selection here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St , where we make it simple for investors like you to stay informed and proactive. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value . This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqCM:TALK NasdaqGM:ARDX and NYSE:YSG . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com Kommentare anzeigen AGB und Datenschutzerkl\u00e4rung Privacy Dashboard Empfohlene Nachrichtenartikel", "symbol": "ARDX", "date": "2024-12-27T17:09:08+00:00", "sentiment": {"score": 0.017510175704956055, "confidence": 0.09379837661981583, "probabilities": {"positive": 0.09379837661981583, "negative": 0.07628820091485977, "neutral": 0.8299134373664856}}, "embedding": [-0.032412897795438766, -0.06439098715782166, -0.035748790949583054, 0.03354157507419586, 0.04680165648460388, -0.019349144771695137, 0.0028555146418511868, 0.039846163243055344, -0.017576009035110474, -0.044951558113098145, -0.09648604691028595, 0.012823265977203846, -0.02719011902809143, 0.0075035784393548965, -0.11305651068687439, -0.05201292783021927, 0.05955340713262558, -0.029409030452370644, 0.06477206945419312, 0.026724813506007195, -0.11132635176181793, -0.06810501217842102, -0.006611444056034088, -0.013819795101881027, -0.023525089025497437, 0.007954997010529041, -0.04484168812632561, 0.06263753026723862, -0.2042991667985916, -0.1746441274881363, -0.09054984897375107, 0.05157275125384331, 0.06281523406505585, -0.0816807895898819, -0.08901538699865341, -0.029688794165849686, 0.10422123968601227, 0.06744734197854996, 0.060967739671468735, -0.04755643382668495, 0.01646706648170948, -0.05397447943687439, -0.048738524317741394, -0.020025383681058884, 0.06693625450134277, -0.12515172362327576, 0.02130872942507267, -0.020799633115530014, 0.09562332928180695, -0.023296836763620377, -0.004810622427612543, 0.08334959298372269, 0.0958966314792633, 0.017397524788975716, -0.131378173828125, 0.11203762888908386, -0.1206301748752594, 0.0010862655472010374, 0.11485607922077179, -0.0558515265583992, 0.04531477391719818, -0.052168503403663635, -0.0012721158564090729, -0.021432941779494286, 0.12583068013191223, 0.002219456247985363, -0.06261823326349258, 0.037880104035139084, -0.03146503120660782, -0.12572364509105682, 0.03972302004694939, -0.024788541719317436, -0.15069684386253357, -0.08565825968980789, -0.10859083384275436, 0.13586977124214172, 0.10601294040679932, -0.06152142211794853, 0.07295702397823334, 0.004216864705085754, -0.1365351378917694, -0.05888860672712326, 0.08234615623950958, -0.06602590531110764, -0.07456785440444946, 0.05998607724905014, 0.05755153298377991, 0.009091170504689217, 0.023255115374922752, -0.12939925491809845, 0.06124836578965187, 0.001975294202566147, -0.14436554908752441, 0.05712581425905228, 0.037319593131542206, -0.0016332166269421577, 0.041059672832489014, -0.011202427558600903, -0.06907296180725098, 0.05090183764696121, 0.27587223052978516, -0.034326788038015366, -0.061932340264320374, -0.09305242449045181, -0.030114131048321724, -0.05708945542573929, 0.0674937292933464, -0.04403920844197273, 0.005078028421849012, 0.03144052252173424, 0.00509218405932188, 0.12010961025953293, -0.11518105864524841, -0.09169117361307144, -0.12297885119915009, -0.026079708710312843, -0.17430345714092255, -0.10400326550006866, 0.17763307690620422, -0.045320384204387665, 0.052365854382514954, 0.07457342743873596, -0.10740122199058533, 0.02176673896610737, -0.07036754488945007, 0.035985998809337616, -0.02186724729835987, 1.620663906243876e-32, -0.0742400586605072, 0.09123171865940094, -0.09818586707115173, -0.11276239156723022, -0.050121456384658813, 0.08014525473117828, 0.05778837576508522, 0.0034706671722233295, -0.11108680069446564, -0.037283755838871, -0.03823965787887573, 0.05227402225136757, -0.07783897966146469, -0.042652323842048645, -0.08532446622848511, -0.18711519241333008, 0.04896491765975952, 0.030982699245214462, -0.02803543582558632, -0.13330501317977905, -0.03138125687837601, 0.177666574716568, -0.12314262986183167, 0.04757034033536911, 0.04356241226196289, 0.005496261175721884, -0.0999159887433052, -0.1265960931777954, -0.0037548094987869263, 0.07394342124462128, -0.006190273445099592, 0.1156650185585022, 0.04794003814458847, 0.010690621100366116, -0.016107145696878433, -0.05606807768344879, -0.10473421216011047, 0.00228290562517941, -0.0122073944658041, -0.1292208433151245, -0.0557645782828331, 0.1563301980495453, -0.11837977170944214, -0.016002848744392395, 0.0011056279763579369, 0.058477580547332764, -0.011592150665819645, 0.13688889145851135, 0.029368624091148376, -0.11167649179697037, -0.17316210269927979, 0.012453231029212475, -0.11159779131412506, 0.07225886732339859, -0.0055608805269002914, 0.00926991831511259, 0.07864326238632202, -0.14729225635528564, 0.04249127209186554, 0.026592621579766273, 0.05442406237125397, 0.14098277688026428, -0.1158415749669075, -0.03631138429045677, -0.09888099133968353, 0.17894673347473145, 0.053945619612932205, 0.08435018360614777, -0.13391296565532684, 0.24798020720481873, -0.029768645763397217, -0.044019848108291626, 0.2344910204410553, 0.05001121014356613, 0.2114962935447693, -0.052493415772914886, 0.01840200275182724, 0.07916725426912308, 0.0967329889535904, -0.10187084972858429, 0.05648141726851463, -0.047384798526763916, -0.0304237212985754, 0.030951257795095444, -0.0015573780983686447, -0.04303240031003952, -0.04495061933994293, 0.09681473672389984, 0.0007400177419185638, -0.1121404767036438, 0.030776305124163628, -0.05899377539753914, 0.08303148299455643, 0.04449259489774704, -0.1282423883676529, -1.6240246445928768e-32, -0.03499719500541687, -0.01207283791154623, -0.031197043135762215, 0.04460373893380165, -0.0012934356927871704, 0.009137436747550964, 0.023749351501464844, -0.07215339690446854, 0.024118490517139435, -0.05878516286611557, -0.014333540573716164, 0.014774320647120476, -0.03498552367091179, 0.035851381719112396, -0.0542159304022789, 0.07437364757061005, -0.010670434683561325, -0.034229762852191925, 0.04771127179265022, -0.09386321157217026, -0.1277492493391037, 0.11738069355487823, -0.13586507737636566, 0.024319076910614967, 0.04931250587105751, 0.01430858951061964, -0.01735643856227398, 0.05797553062438965, 0.017878711223602295, 0.055589281022548676, -0.12115150690078735, 0.06448154151439667, -0.09196252375841141, 0.13196887075901031, -0.048706717789173126, 0.04685118794441223, 0.08211418241262436, -0.025243807584047318, -0.07393718510866165, 0.028639085590839386, 0.04919469356536865, -0.055767495185136795, 0.07145167887210846, 0.0619012825191021, 0.07223653793334961, -0.008560745045542717, 0.0014252178370952606, -0.004508047364652157, 0.05571558326482773, 0.1916632205247879, 0.016550224274396896, 0.03133583813905716, 0.06482338160276413, 0.13555914163589478, -0.13458706438541412, 0.04494640603661537, 0.03357337415218353, 0.12072625756263733, -0.12447737157344818, -0.07257290184497833, -0.029181281104683876, 0.13038669526576996, 0.10017534345388412, 0.0732877179980278, -0.0005517490208148956, 0.009839675389230251, -0.06311735510826111, 0.1161402091383934, -0.07370435446500778, -0.0693349689245224, -0.01332416757941246, -0.006937036290764809, 0.1766209751367569, -0.23241499066352844, -0.03503898158669472, 0.1440815031528473, 0.012406008318066597, 0.005157470703125, 0.04959576576948166, 0.14139172434806824, -0.037042777985334396, 0.106470987200737, 0.06443136930465698, 0.05834660679101944, 0.05924230068922043, 0.08658722043037415, -0.0718572810292244, 0.08553534746170044, -0.018758881837129593, -0.0012637744657695293, 0.00024194549769163132, -0.059773776680231094, 0.046287719160318375, -0.026430871337652206, -0.09399023652076721, -1.0023135388337323e-07, 0.06087443605065346, -0.07169872522354126, -0.07146155834197998, -0.030527565628290176, 0.09509669244289398, 0.0026921103708446026, 0.07197543978691101, 0.03418463096022606, -0.004740962292999029, 0.16146162152290344, 0.13539041578769684, 0.05153804272413254, -0.18724645674228668, -0.03681651130318642, -0.09080567955970764, -0.08496604114770889, -0.061954230070114136, 0.1253369152545929, -0.0019121188670396805, 0.01184939406812191, 0.07061951607465744, 0.11133093386888504, 0.08181323856115341, -0.0418502502143383, 0.020847531035542488, 0.01298646442592144, -0.027703983709216118, -0.009757712483406067, 0.055746953934431076, 0.05208549648523331, -0.04730119928717613, 0.028775477781891823, 0.06461087614297867, -0.08148544281721115, 0.12825831770896912, 0.03606494888663292, -0.060100048780441284, 0.1439630389213562, 0.01875949651002884, 0.050163909792900085, 0.0005641188472509384, -0.12420010566711426, 0.0015013907104730606, -0.04825623705983162, 0.08430583775043488, -0.08844916522502899, -0.12036814540624619, -0.05466960370540619, 0.19132423400878906, -0.13804560899734497, -0.10602819919586182, -0.038796331733465195, 0.01574123650789261, 0.021956035867333412, 0.08126390725374222, 0.12065274268388748, -0.14894379675388336, 0.05552084743976593, -0.09037631005048752, -0.027590863406658173, 0.08012355864048004, -0.22682610154151917, 0.01575876958668232, 0.16734302043914795], "changes": {"1wk": -4.606530637199046, "1mo": 5.9500948274426095}}, {"text": "PREMIUM Ardelyx Insider Bought Shares Worth $996,580, According to a Recent SEC Filing MT Newswires Tue, Dec 24, 2024, 2:00 AM In This Article: ARDX -1.31% David M Mott, Director, on December 19, 2024, executed a purchase for 213,300 shares in Ardelyx (ARD PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2024-12-23T23:00:38+00:00", "sentiment": {"score": 0.034776066429913044, "confidence": 0.04781379550695419, "probabilities": {"positive": 0.04781379550695419, "negative": 0.01303772907704115, "neutral": 0.9391485452651978}}, "embedding": [-0.11139337718486786, -0.1120578870177269, -0.08523581922054291, 0.07769812643527985, 0.02756640687584877, -0.13847234845161438, 0.15849144756793976, 0.010586800053715706, 0.04941822960972786, 0.030617618933320045, 0.016774680465459824, 0.28591859340667725, 0.12508812546730042, 0.001037187990732491, -0.07094532996416092, 0.04063718393445015, 0.017783228307962418, -0.14354634284973145, 0.06301971524953842, 0.07733455300331116, -0.21678908169269562, -0.027191758155822754, -0.01745431311428547, -0.042068906128406525, 0.2460630089044571, -0.06321240216493607, -0.011670035310089588, -0.10637248307466507, 0.0029208892956376076, -0.06346278637647629, 0.023474296554923058, -0.008034175261855125, 0.04074237868189812, 0.002295201411470771, -0.07720322161912918, -0.0007862477214075625, -0.0037527144886553288, 0.057419147342443466, -0.06708083301782608, -0.041297636926174164, 0.07923278957605362, -0.022982779890298843, -0.13276323676109314, -0.07016563415527344, -0.09008079767227173, -0.011958014219999313, -0.04737808182835579, 0.08662840723991394, 0.041498515754938126, 0.1905910223722458, -0.04803253710269928, -0.09185560792684555, 0.0782773345708847, -0.12804172933101654, -0.0027860517147928476, 0.089243583381176, -0.2081795185804367, -0.08865892142057419, 0.02318630740046501, -0.09719960391521454, 0.10066123306751251, -0.05088965222239494, -0.0934804305434227, 0.03559432551264763, -0.07883545756340027, 0.003634571097791195, 0.0829189270734787, 0.01732536032795906, -0.037901487201452255, -0.08932679891586304, 0.25054270029067993, 0.1367475688457489, -0.0391906276345253, -0.12470565736293793, -0.08092036098241806, 0.1564393937587738, 0.1695222556591034, -0.24384626746177673, 0.010798379778862, -0.02239340916275978, 0.017822327092289925, 0.060155581682920456, 0.05735934525728226, -0.0028565889224410057, 0.05775666609406471, 0.04510219767689705, 0.0805896669626236, 0.04002072662115097, 0.013229668140411377, -0.09233041107654572, 0.1283986121416092, -0.052119310945272446, -0.06947074085474014, -0.005158675834536552, -0.10556922107934952, 0.09383184462785721, -0.11793146282434464, 0.06878888607025146, -0.2048790603876114, 0.007181594148278236, 0.06323529034852982, 0.09654001891613007, 0.08865395933389664, -0.017645956948399544, 0.026946987956762314, -0.16463671624660492, 0.1576080322265625, 0.12631964683532715, -0.11642127484083176, 0.050874728709459305, -0.10501445829868317, -0.03144323080778122, -0.10895629227161407, -0.14954812824726105, 0.023367151618003845, 0.057423368096351624, -0.13127805292606354, 0.027472101151943207, 0.044905345886945724, -0.06046892702579498, 0.036458782851696014, 0.1835750937461853, -0.021578501909971237, 0.13382582366466522, 0.0005772208678536117, 0.05467304214835167, -0.004055588040500879, 1.061930135462934e-32, -0.044571276754140854, 0.20111411809921265, -0.08555920422077179, -0.0674210637807846, -0.019814668223261833, 0.07900415360927582, 0.15271170437335968, -0.06161263585090637, -0.056882284581661224, 0.026061778888106346, -0.13396725058555603, 0.10728633403778076, -0.03486911952495575, 0.0620412640273571, -0.02145516313612461, -0.06285243481397629, 0.005433597136288881, 0.06420020014047623, 0.09068933874368668, 0.0010929331183433533, 0.07466460019350052, 0.06639532744884491, -0.09034232795238495, 0.028307434171438217, -0.1316065639257431, 0.004952377639710903, 0.08364084362983704, 0.014042581431567669, 0.07729478925466537, 0.0825829803943634, -0.012751850299537182, 0.14639027416706085, 0.02328231930732727, 0.06212502345442772, -0.04249916970729828, 0.19240686297416687, -0.12313356250524521, -0.03054135851562023, 0.06454160809516907, -0.11009938269853592, -0.14233733713626862, 0.04839196428656578, -0.11802326142787933, -0.2192211002111435, -0.13858164846897125, -0.017337633296847343, -0.11419586092233658, 0.00897675845772028, 0.18052612245082855, -0.11074977368116379, -0.06403902173042297, 0.11247286945581436, -0.09366919100284576, 0.04637858271598816, -0.10242974013090134, -0.08111471682786942, -0.02431861311197281, -0.01780991442501545, 0.17618931829929352, 0.027209823951125145, 0.06038916856050491, 0.059438690543174744, 0.16187578439712524, 0.07298187166452408, -0.29938367009162903, 0.15978141129016876, -0.01963082142174244, -0.07388358563184738, -0.037802428007125854, 0.2004910707473755, 0.0940590500831604, -0.05167229473590851, 0.021205205470323563, -0.19536937773227692, 0.031610023230314255, -0.10557091981172562, -0.02561809867620468, -0.17562511563301086, 0.17196297645568848, 0.15404483675956726, -0.032575443387031555, -0.12561415135860443, 0.13225270807743073, 0.08546874672174454, 0.06854310631752014, 0.05084829404950142, -0.04574493318796158, 0.20589661598205566, 0.08092357218265533, 0.0636151060461998, 0.18679410219192505, 0.04492136836051941, -0.20314185321331024, 0.05510203540325165, 0.03890082240104675, -1.0124842880267392e-32, -0.05319773778319359, -0.014446921646595001, 0.023112276569008827, -0.1475875973701477, -0.19202932715415955, 0.05474475398659706, -0.08957364410161972, 0.2501877248287201, -0.07099689543247223, 0.03549262136220932, -0.0314030796289444, 0.12089014798402786, -0.18938729166984558, 0.08260012418031693, -0.037196218967437744, -0.08083795756101608, 0.0649062916636467, -0.10303312540054321, 0.1865512728691101, -0.012831566855311394, -0.12120840698480606, 0.017147405073046684, -0.06712568551301956, 0.1947222799062729, 0.06271523237228394, 0.03401382640004158, 0.05613360553979874, 0.03499520197510719, 0.051840707659721375, -0.032974015921354294, -0.061166394501924515, -0.041586216539144516, -0.1292179822921753, 0.07702478766441345, -0.03233588486909866, -0.008141485042870045, 0.1881473809480667, 0.14166861772537231, -0.009032190777361393, -0.10378812253475189, 0.056625887751579285, -0.055622391402721405, 0.1288016140460968, 0.07190891355276108, 0.26022812724113464, -0.062098633497953415, 0.10088988393545151, -0.17934925854206085, 0.0600927509367466, -0.15142422914505005, 0.0033923378214240074, -0.07077586650848389, 0.3006802797317505, 0.1538459062576294, -0.16432039439678192, 0.03585973009467125, -0.04563968628644943, 0.08537702262401581, 0.2047140747308731, -0.10082067549228668, -0.027234623208642006, 0.2155188024044037, -0.21237938106060028, 0.07421649247407913, -0.1764458268880844, 0.0016353721730411053, 0.0099648367613554, -0.10312634706497192, -0.1808454692363739, -0.11724262684583664, -0.08541757613420486, -0.0693017840385437, -0.06863035261631012, -0.18302154541015625, 0.04110439494252205, 0.14336155354976654, -0.04057023301720619, -0.015925494953989983, 0.06570608913898468, 0.031123055145144463, 0.11260034888982773, 0.02162761799991131, 0.005224089603871107, 0.03879750147461891, -0.10763434320688248, -0.07461989670991898, 0.08177230507135391, -0.001597294700331986, -0.09768503159284592, 0.013200950808823109, -0.24543558061122894, 0.024816762655973434, -0.07750644534826279, -0.1458996832370758, 0.1044970154762268, -1.0015050122547109e-07, -0.010444987565279007, 0.03915011137723923, 0.030909715220332146, 0.019296497106552124, 0.1147560402750969, 0.027170775458216667, 0.023076120764017105, 0.1428932547569275, 0.04516104981303215, 0.21683037281036377, -0.009762067347764969, -0.07060111314058304, -0.12604762613773346, -0.04708367958664894, -0.1175902783870697, -0.08790446072816849, 0.026530368253588676, -0.029167864471673965, 0.08348524570465088, -0.0007205153815448284, 0.11741317063570023, 0.19329328835010529, 0.1332322061061859, -0.10188368707895279, -0.05561758950352669, 0.06996891647577286, 0.006871358957141638, -0.039727307856082916, 0.0032605775631964207, -0.006665514782071114, -0.05465405061841011, 0.010145123116672039, -0.06127520278096199, 0.017240062355995178, 0.02544298581779003, 0.041703809052705765, 0.003802543506026268, 0.07106555253267288, -0.02870502509176731, 0.0007717713597230613, -0.10318263620138168, -0.07260259240865707, 0.05587001144886017, -0.06429153680801392, -0.053734391927719116, 0.0471908301115036, -0.2556842267513275, -0.3137168288230896, 0.18145960569381714, -0.06221510469913483, 0.1690228134393692, -0.1219131350517273, 0.14662852883338928, -0.043870169669389725, -0.10436397045850754, -0.07655320316553116, -0.015628928318619728, -0.10864724963903427, -0.15873487293720245, 0.03508937731385231, 0.06032942607998848, -0.2863924205303192, -0.18672919273376465, 0.10414605587720871], "changes": {"1wk": 14.628822870193261, "1mo": 10.262014734893112}}, {"text": "PREMIUM Ardelyx Shares Fall After Federal Judge Dismisses Lawsuit Against CMS MT Newswires Fri, Nov 8, 2024, 9:39 PM 1 min read In This Article: ARDX -1.31% Ardelyx Shares Fall After Federal Judge Dismisses Lawsuit Against CMS PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ARDX", "date": "2024-11-08T18:39:46+00:00", "sentiment": {"score": -0.2414034940302372, "confidence": 0.2724159061908722, "probabilities": {"positive": 0.031012412160634995, "negative": 0.2724159061908722, "neutral": 0.6965717077255249}}, "embedding": [-0.0809049904346466, -0.06786025315523148, -0.011720377020537853, 0.17297375202178955, 0.13721948862075806, -0.005543947219848633, 0.0739547461271286, -0.055330850183963776, -0.018725579604506493, 0.07138840109109879, 0.05499754101037979, 0.351198673248291, 0.13578486442565918, 0.006105771753937006, -0.0013515809550881386, 0.027914661914110184, 0.025915753096342087, -0.11844287812709808, -0.02697802521288395, 0.10524021834135056, -0.20125757157802582, -0.04563480243086815, -0.11710980534553528, 0.007754137273877859, 0.11701523512601852, -0.0610518604516983, -0.14025664329528809, -0.08140972256660461, -0.0811927393078804, -0.137674942612648, -0.03362102061510086, -0.023534473031759262, 0.043420348316431046, -0.0076767075806856155, -0.020280787721276283, -0.06938378512859344, -0.018407931551337242, -0.03301142901182175, -0.1359253078699112, -0.053816892206668854, 0.06266447901725769, 0.005474230740219355, -0.10977855324745178, 0.02293069288134575, -0.157925084233284, -0.007630880922079086, 0.04949807748198509, 0.06459792703390121, -0.020273106172680855, 0.17140933871269226, -0.08675117790699005, -0.15457691252231598, 0.18928328156471252, 0.002508132718503475, -0.0906173512339592, 0.13183102011680603, -0.25152352452278137, -0.06676211953163147, -0.015957623720169067, -0.09452338516712189, 0.09544412791728973, -0.042097434401512146, -0.16481757164001465, 0.09587372839450836, -0.07677986472845078, 0.13170090317726135, 0.11917408555746078, 0.06074798107147217, -0.045692019164562225, -0.06420628726482391, 0.23055897653102875, 0.06550679355859756, -0.05043768137693405, -0.050039853900671005, -0.007030459586530924, 0.33222290873527527, 0.2629585862159729, -0.21422666311264038, 0.19792358577251434, -0.14434102177619934, -0.08502095937728882, 0.007019705604761839, 0.023836959153413773, -0.0629846453666687, 0.013493825681507587, -0.010174136608839035, 0.08383829891681671, -0.11225154250860214, -0.05480417236685753, -0.21786998212337494, 0.2539459764957428, -0.0037342598661780357, 0.0810827985405922, 0.0148170106112957, -0.01326600369066, -0.0014114902587607503, -0.00977893266826868, -0.04202750697731972, -0.08447040617465973, 0.0696331039071083, 0.04443257302045822, 0.11921443045139313, 0.013247199356555939, -0.008900895714759827, 0.05083351954817772, -0.17369939386844635, 0.1175568550825119, 0.1040811613202095, -0.08038715273141861, 0.04532713443040848, 0.029115738347172737, 0.015447340905666351, -0.013621363788843155, -0.16183874011039734, -0.07987559586763382, 0.16385230422019958, -0.11426177620887756, 0.03770357370376587, 0.05842995271086693, -0.08123593777418137, -0.07986707985401154, 0.2544824779033661, -0.16833344101905823, 0.08365858346223831, 0.119385726749897, 0.0992683470249176, -0.06087612733244896, 1.5493706146768857e-32, -0.18399368226528168, 0.02007565088570118, -0.07972999662160873, -0.1456996351480484, 0.08990751206874847, -0.0395343080163002, 0.15262426435947418, -0.0723060891032219, -0.0897030457854271, -0.04819200560450554, -0.20376688241958618, 0.16087985038757324, -0.029022451490163803, -0.07258641719818115, -0.07079562544822693, -0.04568898305296898, 0.02542942948639393, 0.0811273530125618, 0.07075557857751846, 0.04442591592669487, 0.046241577714681625, -0.006121669430285692, -0.09818227589130402, 0.0637502446770668, -0.17510148882865906, 0.03979739174246788, 0.12492014467716217, -0.011537770740687847, 0.05850072577595711, 0.10396209359169006, -0.058089811354875565, 0.15435320138931274, 0.04728541523218155, 0.043919917196035385, 0.019561875611543655, 0.21904847025871277, 0.005689314566552639, 0.13941682875156403, 0.032040126621723175, -0.14225776493549347, -0.1847226768732071, -0.012364266440272331, -0.1592840552330017, -0.10123500227928162, -0.09616642445325851, -0.15848276019096375, -0.15287086367607117, -0.1050005555152893, 0.1252242624759674, -0.06421004980802536, 0.06008211150765419, 0.04324254021048546, -0.014799914322793484, 0.10231450200080872, -0.09589993953704834, -0.0066854809410870075, -0.14787454903125763, -0.01619669236242771, 0.21190330386161804, -0.07910806685686111, 0.14853538572788239, 0.0983223021030426, 0.09958642721176147, 0.021189283579587936, -0.17191284894943237, 0.07442606985569, 0.02108450047671795, -0.09481654316186905, -0.22128047049045563, 0.06675537675619125, 0.12011147290468216, 0.025847630575299263, 0.03198623284697533, -0.09121190011501312, -0.02665497362613678, -0.09448739141225815, -0.13800570368766785, -0.18299143016338348, 0.22435712814331055, 0.10928890109062195, 0.014253209345042706, -0.16052205860614777, 0.1416030079126358, 0.06391900777816772, 0.050782397389411926, -0.10508492588996887, -0.006243828218430281, 0.10127927362918854, 0.03726448863744736, -0.013176788575947285, 0.09750465303659439, 0.027221394702792168, -0.05510253086686134, 0.19319814443588257, 0.1359865665435791, -1.5058720339718824e-32, -0.16957572102546692, -0.08850905299186707, -0.007718028966337442, 0.007020279765129089, -0.25908032059669495, 0.017237460240721703, -0.09203896671533585, 0.20969705283641815, -0.0724567249417305, 0.02880365028977394, -0.035000529140233994, 0.08626310527324677, -0.2737891972064972, 0.08002600818872452, -0.10307016223669052, 0.006069622468203306, 0.11076502501964569, -0.15230432152748108, 0.07498423010110855, 0.07939999550580978, 0.01881049945950508, 0.00441707530990243, -0.166603684425354, 0.22162054479122162, 0.08080408722162247, -0.0033125141635537148, 0.14857874810695648, -0.042786698788404465, 0.092669777572155, -0.04453103989362717, -0.04899653047323227, -0.02343377098441124, -0.2196166068315506, 0.06786655634641647, 0.03091503493487835, -0.010596534237265587, 0.14322076737880707, 0.09762340784072876, -0.14115241169929504, -0.11369951069355011, 0.005162387620657682, -0.05087225139141083, 0.09666100889444351, 0.10431333631277084, 0.2774028480052948, 0.030565274879336357, 0.15350760519504547, -0.08838723599910736, 0.10440976917743683, -0.12148525565862656, -0.0365365631878376, -0.20599348843097687, 0.31423574686050415, 0.12859812378883362, -0.1577492356300354, -0.005406998097896576, 0.026158146560192108, 0.07705030590295792, 0.03093688376247883, -0.02273167110979557, 0.09321413934230804, 0.10612960159778595, -0.2541019320487976, -0.046705350279808044, -0.062540702521801, 0.07724811881780624, -0.024626532569527626, -0.047309719026088715, -0.036349277943372726, 0.002893397118896246, 0.019315429031848907, 0.0019342068117111921, -0.04095403477549553, -0.2183394581079483, 0.13349610567092896, 0.2746949791908264, 0.08431648463010788, 0.06546942889690399, -0.13887424767017365, -0.012965306639671326, 0.24356627464294434, -0.022893421351909637, -0.08650515228509903, 0.04036283493041992, -0.13573306798934937, 0.018048109486699104, 0.10187464952468872, -0.0977482870221138, -0.16201621294021606, 0.08928782492876053, -0.24824140965938568, -0.061705611646175385, -0.0576961413025856, 0.05877971276640892, 0.02490146830677986, -1.0093423696844184e-07, 0.015009455382823944, -0.008761819452047348, -0.022779274731874466, 0.009140110574662685, 0.08624773472547531, 0.012862670235335827, 0.048565518110990524, 0.05875033885240555, 0.05990007519721985, 0.10485794395208359, -0.01683148741722107, -0.02532636933028698, -0.08162026107311249, -0.02237970381975174, -0.07482071965932846, -0.08225396275520325, 0.13351409137248993, 0.0016812217654660344, 0.021366223692893982, -0.06864513456821442, -0.06625781208276749, 0.06995685398578644, 0.14148633182048798, -0.1546574831008911, 0.014940462075173855, 0.0008714415016584098, 0.0493052713572979, -0.05097629874944687, -0.026701446622610092, -0.015706786885857582, -0.09194255620241165, 0.09023887664079666, -0.13501954078674316, -0.03140665963292122, 0.0019497881876304746, 0.003808310255408287, 0.05330426245927811, 0.1244003102183342, 0.12500418722629547, -0.09539655596017838, -0.11968383193016052, 0.09872705489397049, 0.0837291032075882, -0.04858791455626488, -0.003752428572624922, -0.05446343123912811, -0.11352872103452682, -0.12861405313014984, 0.24480994045734406, -0.10864336043596268, 0.08084571361541748, -0.2842060327529907, 0.1172432154417038, -0.13928745687007904, -0.07377597689628601, 0.03088083118200302, 0.07693369686603546, -0.04121854156255722, -0.15804614126682281, -0.07801618427038193, 0.05669727548956871, -0.26745328307151794, -0.1361180692911148, 0.17380914092063904], "changes": {"1wk": -1.9723940450470965, "1mo": 12.820504862375111}}]